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INTRODUCTION 
Lymphoid leukosis (LL) is a virus-induced lymphoblastic malignancy 
originating in the bursa of Fabricius. This is a cancer-like disease and 
affects almost any tissue of a chicken producing tumors. The disease is 
initiated by an RNA group of a Myxo virus. Chickens are infected either 
congenitally, through the egg (vertical transmission), or by direct 
contact with infected chickens (horizontal transmission) (Siccardi and 
Burmester, 1970). 
LL has been responsible for one of the most costly disease problems 
confronting the poultry industry in the past. Its seriousness today seems 
to have considerably lessened. Purchase, et al. (1972), in a survey of 
more than 145,000 birds over a period of approximately 18 months, reported 
an average of 3.3% mortality due to LL. Lifetime losses from LL amounted 
to 1.2 to 3.4% in experimental strains of Leghorns and meat-type breeders 
(Gavora, et al., 1975). In large-field surveys conducted in Great Britain, 
1.4% of all laying flocks (Randall, et al., 1977) and 1.5% in broiler 
breeder flocks died from LL. In some flocks, much higher losses from LL 
have been experienced (Jones, et al., 1978; Crittenden and Witter, 1978). 
Recently, the effects of LL virus on production and mortality were 
investigated in approximately 2000 Leghorn pullets in each of two consecu­
tive years (Gavora, et al., 1980). The pullets were from nine strains 
developed in Ottawa, of which three were unselected control strains and 
six were strains under selection for up to 27 generations for high egg 
production and a complex of related commercially important traits. The 
overall frequency of birds shedding LL virus or group specific antigens 
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into eggs (LL-S) was 3.9% in the selected strains and 18.5% in the control 
strains. The LL-S pullets produced 30 and 25 eggs less per hen-housed 
than the nonshedders in 1976 and 1977, respectively. Also, the LL-S 
birds reached sexual maturity later, produced smaller eggs at a lower rate, 
and their eggs had a lower specific gravity, indicating thinner shells. 
Mortality from all causes to 497 days of age was significantly higher in 
the LL-S birds (+14.8%) in 1976. The eggs from LL-S dams had 2.4% lower 
fertility and 12.4% lower hatchability. The rearing of large numbers of 
birds under crowded conditions leads to much bird-to-bird contact and a 
contaminated environment. Tumors became a major cause of death loss. 
On the other hand, chickens have played a leading role in tumor 
virology because viruses causing cancerous growths were discovered and 
isolated from chickens many decades before they were recognized in other 
animal species. Chickens have a relatively short life cycle, produce a 
large number of offspring, and are easy to grow and maintain under 
laboratory conditions. Also, the embryonated chicken egg is very conven­
ient and, therefore, commonly used as a host for the study of viruses. 
Little did we know that the first recognized transmission of a solid 
tumor (sarcoma) in chickens using cell-free inocula reported by Peyton Rous 
in 1911, was to be of such importance in resolving the avian leukosis 
problem 50 years later. The significance of this work to medical science 
was belatedly recognized by the awarding of a Nobel Prize to Rous in 1966. 
In addition, a most remarkable discovery in the field of avian 
immunogenetics has been the role of the major histocompatibility complex 
(MHC) in the genetic control of immune functions. The development of 
congenic inbred lines in the chicken is useful for studies of genetic 
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differences in the MHC. In the chicken, the acute skin graft rejection, 
the mixed lymphocyte reaction, cell-mediated immune response to viral 
oncogenesis, humoral immune response, and serologically-defined antigens 
are all under genetic control by the B complex. 
The purpose of this study was to further investigate the role of B 
complex in the control and fate of Rous sarcoma viruses induced-tumors in 
the chicken. The significance of inbreeding and gene frequency on 
fixation of tv and rs genes has also been examined along with an attempt 
to answer the question as to whether there is a single locus linked to 
the B complex, which controls the genetic expression of all virus 
subgroups (single locus hypothesis) or whether the B complex carries 
separate loci each controlling resistance or susceptibility to tumors 
induced by different avian sarcoma virus subgroups. Finally, the question 
of genetic linkage of immune response locus (Ir-GAT), which controls 
antibody production to the amino acid polymer, GAT, and the RSV genes, 
which control tumor regression to RSV-subgroup A has been studied. 
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REVIEW OF LITERATURE 
The B System and Histocompatibility 
Thirteen autosomal blood group systems have been described thus far 
in chickens (Briles, 1962; Crittenden, et al., 1970). These are designated 
alphabetically: A, B, C, D, E, H, I, J, K, L, N, P and R. Among these, 
the B system (Briles, et al., 1950) occupies an exceptional position with 
regard to the complexity of its antigens (Briles, et al., 1950; Gilmour, 
1959). The B system is highly polymorphic. Antigens are located on the 
surface of both erythrocytes and lymphocytes. 
Shortly after its discovery attracted attention of the investigators 
that different genotypes of this system may influence viability, hatch-
ability and a number of economically important traits (Gilmour, 1960), 
Schierraan and Nordskog (1961) reported that the B locus controls trans­
plantation immunity using the skin grafting technique. Thus, they 
identified B as the major histocompatibility locus in chickens. Jaffa and 
McDermid (1962) showed that B locus controlled splenomegaly. They identi­
fied it as the major GVH splenomegaly locus. Schierman and Nordskog (1963) 
showed that B also controlled lymphocyte foci development using the 
chorioallantoic membrane (CAM) test. They identified it as the major 
GVH-CAM pock locus. Miggiano, et al., (1974) used the B genotype to 
identify a mixed-lymphocyte-reaction (MLR) locus. They showed that the MLR 
is controlled by a separate locus closely linked to B locus. These results 
leave no doubt that the B blood group locus identifies with the major 
histocompatibility complex of the chicken. 
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The Structure of the MHC 
The best known MHC is the H-2 system of the mouse. It consists of a 
complex of loci responsible for a number of traits (Klein, 1975). Sero­
logically detectable H-2 antigens are determined by alleles of two loci, 
H-2K and H-2D. These loci are located in the end regions of the H-2 com­
plex, and recombinants with a 0.5% frequency have been found between them 
(Shreffler, 1970). However, little is known of the number and arrange­
ment of genes in the chicken MHC, although it is of great interest to 
compare the genetic organization of the MHC*s of various species; for 
example there are differences in the number and arrangement of loci in the 
H-2 in the mouse and the HLA complex in man (Klein, 1975). 
Schierman and McBride, (1969) noted the occurrence of unusually rapid 
skin rejection among a group of recipient-donor pairs matched for compat­
ibility on the basis of B hemagglutination reactions. The exceptional 
2 3 
recipient, a female, was originally typed as B B , but after investigation 
2 4 
she was redesignated B B to indicate the uniqueness of the new allele, 
3 2 3 
classified earlier as B . When normal B B heterozygotes received skin 
from the B^B'^ female, the graft was tolerated in a manner characteristic 
of non-B histocompatibility antigens. Thus, all data presented in this 
first report were compatible with the aberrant type B^, having resulted 
2 from a recombination between chromosomal segments coding for the B and 
3 
B alleles. 
The second report of a probable recombinant in the B system was by 
Hall, et al., (1975 and 1976). Three inbred lines CB (B^B^), CC(B^B^), 
and WB(B^'^B^^), homozygous for transplantation and erythrocyte antigens 
were used in a special cross (CC X CB) X WB to produce B^B^^ and 
6 
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B B chicks to be grafted with skin from congenic grandparent lines CC 
1 2 
and CB. Typical segregation of B and B occurred in all but two of 1,206 
chicks resulting from the mating. In addition to B^^, erythrocytes of each 
of these exceptional chicks (males) were agglutinated by both reagents B^ 
2 
and B . Male no. 744, was identified as a cross-over both within the 
region coding for seriological determinants, but outside the region coding 
also for histocompatibility determinants. BalS, et al. (1976 and 1977) 
designated the putative locus determining the SD and H antigens B-F and 
the other determining other SD antigens as B-G (Fig. 1). In addition, the 
immunochemical approach (Ziegler and Pink, 1976) and tolerance induction 
(Hartmanova et al., 1977), has led to roughly the same conclusions. Studies 
of Pink et al., (1977) indicate that the chicken B complex includes at 
least three regions: B and B-L within the B-F region plus the original 
B-G region (Fig. 1). Biochemically, the B-L region may be homologous to 
la antigens. The evidence for a duplicate-like gene (as K-D in H-2) could 
not be substantiated by Pink et al., (1978); they favor the single locus 
hypothesis. However, cytogenetic and immunologic features of chicken 
cells have been studied in an effort to relate the B-blood group locus to 
a specific chromosome. According to a Bloom and Cole (1978), the B locus 
is linked to the nucleolus organizer region (NOR) on one pair of acrocentric 
chromosomes rank in the size and ranged from 15 to 18. 
Immune response to various antigens in different animal species is 
controlled by specific immune response (Ir) genes linked to the major 
histocompatibility complex (Benacerraf and Katz, 1975). Similarly, the 
MHC of the chicken exerts genetic control of immune response to various 
antigens. Control of immune response by the B-complex has been reported 
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for Salmonella Pullorum bacterin (Pevzner, et al,, 1973 and 1975), tuber­
culin (Karakoz, et al., 1974), 2, 4-dinitrophenol group conjugated to 
chicken gamma globulin (DNP-CGG) (Balcorova, et al., 1974), and the 
synthetic polypeptides (T,G)-A—L (tfunther, et al., 1974 and Balcarova, 
et al., 1975), GAT (Benedict, et al., 1975), and GT (Koch and Simonsen, 
1977). Recently, immune response to (L-glutaraic acid^^, L-alanine^^, 
L-tyrosine^^) (GAT) has been shown to be controlled by a distinct Ir gene 
linked to genes coding for the B serologically-determined (SD) antigens 
1 19 (Pevzner, et al., 1978). Ir-GAT and Ir-GAT alleles control low and high 
immune response to GAT, respectively. A recombinant between B^B^ and 
19 19 11 
B B proved to be a high responder to GAT but serologically testing B B . 
> 1 1 
Thus, the crossover involved the SD region of B B and the IR region of 
19 19 
B B . This lead to the conclusion that immune response to GAT is 
controlled by the Ir-GAT gene which is linked to the SD locus of the B 
complex. The GAT locus evidently divides the B-F region into B sub-regions 
and IR (B-L in the Hala - pink model). The latter is an immune response 
region, containing the Ir-GAT locus (Pevzner, 1979) (Fig. 2). 
The gene controlling the fate of tumors induced by Rous sarcoma virus 
(RSV) subgroup A was studied by Gebriel, et al., (1979). Birds carrying 
the dominant allele regress the tumor; homozygous recessive (progressors) 
develop large tumors and die. Their results showed that all the chickens 
developing tumors from inoculation of RSV-subgroup A lacked cellular 
resistance. The rate of tumor regression between the high and low GAT 
responders differed and was highly significant. Thus, it is evident that 
the locus controlling the fate of RSV-induced tumors is closely linked to 
the locus controlling immune response to GAT (Fig. 2). 
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The terra, allo-aggression, first used by Jerne (1971), specifies 
certain cellular reactions resulting from encounters of allogeneic 
lymphocytes. This may occur both in vivo and in vitro, but is usually not 
provided by xenogeneic cells or, if so, only to a much smaller degree. 
Earlier, Simonsen (1975) proposed the existence of phylogenetic factors 
such that certain xenogeneic cells fail to induce GVHR. This led him to 
propose the existence of allo-aggression (AA) gene(s), which were thought 
to be component(s) of the MHC genome and control the allo-aggression 
reaction. The gene product(s) of the AA locus would appear to be expressed, 
not only in T cells, but also in the nucleated erthrocytes, which would 
then permit their detection by hemagglutination. If so, there would be 
no need to make a distinction between SD and LD determinants. The AA 
gene(s) product is present in both bursa cells and the thymus of bursec-
tomized birds. Within the limits of our current knowledge, it seems likely 
that the AA locus forms a part of, or is identical with, the B region 
because the respective antibodies can be absorbed by erythrocytes. So far, 
recombinations between the B-L and B loci have not been observed. 
A condensation of current information on the structure of the chicken 
MHC from Hala's laboratory is presented in Fig. (1). Based on Pevzner's 
and Gebriel's studies at Iowa State University, a new linear order of 
genes in the B-complex can be proposed as in Fig. (2). The SD region may 
consist of two loci, as in the human HLA system, but in chickens, this 
has not yet been demonstrated. The IR region includes the Ir-GAT locus 
and possibly also the (R-Rs, r-Rs) tumor-regressing locus. 
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B complex 
Region (determined 
by crossing-over) B-F B-G 
Loci (determined by 
biochemical analysis) 
WBC agglutination 
RBC agglutination 
Antigen found on 
Analogous regions in 
the mouse H-2 
Antigenic effects 
RBC 
lymphocyte 
K (or D) 
B-L 
lymphocyte 
lA 
Line Origin 
SD determinants 
H determinants 
MLR determinants 
CB 
B-G 
RBC 
SD deter­
minants 
CC 
Figure 1. Structure of the chicken major histocompatibility complex 
(from Hala et ai., 1977) 
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B complex 
Region (determined by 
crossovers) 
Genes 
SD IR B-G 
Ir- Rs 
B GAT rs 
X X 
WBC antigens + 
RBC antigens + 
Figure 2. B-coraplex: a linear order of genes (from Pevzner, 1979; Gebriel 
et al., 1979) 
Genetics and Control of Lymphoid Leukosis Viruses 
The avian leukosis-sarcoma viruses have been divided into five sub­
groups A, B, C, D and E (Vogt, et al., 1967; Duff and Vogt, 1969; and 
Hanafusa, et al., 1972). The main principles involved in applying genetic 
resistance to the control of lymphoid leukosis disease and the actual and 
potential importance of this approach to disease control are considered in 
terms of the following: (1) mechanisms of resistance, including virus 
receptors, (2) recognition of resistance, (3) role of cell mediated immunity 
(4) inheritance of resistance, including simple and polygenic control, and 
(5) selection for resistance (Gyles and Brown, 1971; and Payne, 1973). 
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Mechanisms of resistance 
The chicken has developed a variety of mechanisms for resistance 
which are under genetic control. Resistance, that is, the ability to 
withstand the pathogenic effects of the parasite, is usually highly 
specific to the parasite in question. The ability of avian leukoviruses, 
such as Rous sarcoma virus (RSV) and lymphoid leukosis virus (LLV), to 
infect chicken cells is dependent on the presence on the cell membrane of 
specific virus receptors necessary for uncoating of adsorbed virus 
(Piraino, 1967). Single recessive autosomal genes code for absence of 
receptors for leukoviruses of each of subgroups A, B, C and possibly D 
and E (Payne, 1973). If the block to the uncoating process is by-passed, 
resistant cells are found to support virus replication (Crittenden, 1968). 
Vogt and Ishizaki, (1965) suggested a phenotypic nomenclature based on 
the terminology for host bacterium resistance use by bacteriophage workers. 
The phenotypes of the cells are designated C/0, C/A, and C/A,B. The C 
stands for "chicken" and the bar for "resistant to" and the A and B 
represent the excluded virus subgroups. The phenotypes are controlled by 
two independent autosomal loci, called the tumor virus a (tva) and the 
S s 
tumor virus b (tvb) loci. The genes controlling susceptibility (a , b ) 
appear to be dominant over the alleles controlling resistance (a^\ b^) 
(Crittenden, et al., 1967). 
Two levels of genetic resistance to lymphoid leukosis viruses are 
recognized (Crittenden, 1975). The first is cellular resistance, i.e., 
a mechanism that prevents the virus from penetrating living host cell. 
It has been clearly shown that cellular resistance to subgroups A, B and 
C is controlled, in each case, by a single autosomal recessive gene. Thus, 
the tva locus controls resistance to subgroup A viruses with suscepti­
bility being completely dominant to resistance. The second line of 
defense involves a mechanism of genetic resistance to tumor growth which 
comes into play after the virus has penetrated the cell. In addition, 
1 13 15 1 
studies on eight inbred lines homozygous for B , B , or B ' blood types 
confirm that the genetic mechanism for cellular resistance is not 
associated with the MHC (Gebriel and Nordskog, 1980). 
Recognition of resistance 
Certain genes with an easily observable phenotypic expression called 
marker genes, may be associated with some other trait. For example, 
differences in alleles at the B blood group locus have been associated 
with differences in susceptibility to Marek's disease (MD) (Hansen, et al., 
1967; Brewer, et al., 1969). The reason for the association has not been 
fully elucidated although Nordskog (1972) suggested the association of 
viability with B blood group differences as being due to linkage. 
Crittenden, et al. (1970) found an association between the R blood group 
antigen and the tvb locus controlling susceptibility to subgroup B 
leukoviruses. Fani, (1974) found a 4-fold resistance to RSV to be associ­
ated with the presence of the homozygous recessive black plumage gene i*. 
Recent studies of Collins, et al., (1977); and Schierman, et al., 
(1977) independently showed that regression of Rous sarcoma virus (RSV)-
induced tumors was a dominantly inherited trait controlled by a gene 
within, or closely linked to, the B MHC. More recently, Marks et al. 
(1979) studied the incidence of tumor regression in two highly inbred 
lines of East Lansing White Leghorns, 6^ and 7^ plus their and 
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reciprocal backcross progeny. These lines evidently do not differ in 
their serological or histocompatibility alloantigens associated with 
the B blood group locus. In addition, Collins, et al., (1980) demonstrated 
marked genetic differences in tumor regression between inbred lines which 
share similar, if not identical, B locus erythrocyte alloantigens so 
that other unknown genes are probably also involved. However, Gebriel, 
et al., (1979) showed that the (Rs, rs) locus is closely linked to the 
Ir-GAT locus and, therefore, maps within or close to the Ir-region of the 
B MHC. Such markers are of interest as possible criteria for detecting 
and selecting disease-resistant fowl. 
Role of cell-mediated immunity 
Alterations in cell-mediated immunity (CMI) have been associated 
with oncogenesis. Cell-mediated immune cytotoxicity was lower in avian 
leukosis virus infected chickens with overt disease, but was normal in 
sub-clinically infected chickens (Granlund and Loan, 1974). Thymectomy 
did not alter the course of lymphoid leukosis in chickens (Peterson, et 
al., 1964). In addition, antithymus serum prevented development of Marek's 
disease lesions following virus inoculation (King, et al., 1972). The 
growth of Rous sarcomas was enhanced by immunosuppression (Halleux, 1971; 
Law, et al., 1968; and Sjogren and Borum, 1971). 
Findings by Cotter, et al., (1975) were compatible with the suggestion 
of Rubin (1962) that Rous tumor regression and the restriction of meta­
stasis of such tumors, are controlled by T-cell-mediated immune response. 
Radzichovskaja (1967a and b) has shown that Rous virus tumor growth was 
I 
stimulated in thymectomized chickens but unaffected in bursectomized 
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chickens. Recently, Vlaovic, et al., (1977) concluded that the immuno­
suppression of chickens infected in ovo with avian leukosis virus (RSV-1) 
by the injection of antilymphocyte serum did not significantly (P < 0.05) 
inhibit tumor regression but rather enhanced tumor metastasis. 
Inheritance of resistance 
Control of inheritance of resistance can be classified as single 
gene control or as polygenic control. In single gene control the 
susceptibility or resistance traits are clearly defined with no inter­
mediate forms, and conform to simple Mendelian segregation ratios. The 
best example of single gene inheritance of disease resistance in fowl is 
the control of susceptibility of cells to infection by RSV or LLV of 
subgroups A, B and C. Resistance is controlled by single autosomal 
recessive genes (Crittenden and Okazaki, 1965; and Payne and Biggs, 1966). 
These studies were made in highly inbred lines of chickens, the use of 
which greatly simplifies the genetic analysis of qualitative traits by 
avoiding the complication of heterozygosis at individual loci. Neverthe­
less, inbred stock are not essential for detection of single gene effects, 
as exemplified by the analysis by Pani and Biggs (1973) of response to RSV 
of progeny from two noninbred commercial lines. As with inbred birds, 
they found a major genetic influence of genes at a single locus, accounting 
for 53% of the total variance compared with 0.7% due to genes at other 
loci. 
When a trait is controlled by more than a few pairs of genes, it 
becomes difficult to identify distinct phenotypes. This is due to the 
cumulative effects of many genes. The estimate of the proportion of 
variation in a population which is of additive genetic origin and respon­
sible for resemblance between relatives, and on which selection is based, 
p 
is termed heritability (h ); it is defined as the ratio of additive 
genetic variance to total phenotypic variance, VA/VP (Falconer, 1960). 
2 Some examples of h calculated for disease resistance are: leukosis 
(Lush, et al., 1948) 0.058; lymphomatosis (Robertson and Lerner, 1949) 
0.048; Marek's disease (Von Krosigk, et al., 1972) 0.10 - 0.20; and Rous 
sarcoma (Pani and Biggs, 1973) 1,59; (Bower, 1962) 0,28. 
In White Leghorn strains of fowl, it has been shown that the two 
loci, tva and tvc for cellular resistance are linked (Payne and Pani, 
1971; Pani, 1974). This has recently been confirmed in the Rhode Island 
Red breed (Dren and Pani, 1977). The linkage value of 0.22 in the male 
sex agreed well with the reported in White Leghorn male sex, indicating 
that the two loci are located in the same sites in homologous chromosomes 
in the two breeds. However, in the Rhode Island Red, no sex differences in 
crossing over between the two linked loci were found. 
On the other hand, Crittenden, et al., (1972) concluded that the 
genetic resistance of chickens to lymphoid leukosis is a highly complex 
trait, but that at least one simply inherited mechanism of resistance 
exists which acts at the level of virus infection. Other complex factors 
govern the bird's ability to cope with this infection. In addition, 
Schierman, et al,, (1977) found that regression of RSV tumors, induced 
by the Schmidt-Ruppin strain of subgroup B, is determined by a dominant 
gene designated R-Rs-l, The recessive allele designated r-Rs-1, permits 
uncontrolled (progressive) tumor growth in homozygous birds. 
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Selection 
The main systems of artificial selection include mass selection, 
family selection, combined selection utilizing information from both 
individual phenotypes and families and various techniques to select for 
multiple characters simultaneously e.g., selection index. Several 
investigators have conducted selection studies for resistance and suscep­
tibility of chickens to avian leukosis. McClary, et al., (1951); Waters 
(1951); and Bears, et al., (1963) all reported varying degrees of 
success in selecting divergent lines, from the same original stock for 
resistance and susceptibility to avian leukosis complex. The duration 
of these selection experiments ranged from four to twenty-eight generations. 
The basis of selection most often used was full-sib family selection, 
although progeny testing was employed in some studies. The criterion of 
selection was the percentage of mortality from all subgroups of leuko-
viruses during the rearing and laying periods. Natural exposure was 
usually the sole means of challenge. In a few instances, tumor material 
was placed in the drinking water. 
The most striking example of the results of progeny testing for 
selecting susceptible and resistant stock is that of Cole (1968 and 
1972). By determining the progeny response to inoculated MD tumor cells, 
he selected, in four generations, a resistant line with 6.5% susceptibility 
to MD and a susceptible line with 94.4% susceptibility from common stock 
with an average susceptibility of 51.1%. Progeny testing, used under 
commercial conditions to select for MD resistance, has been reported by 
Friars, et al., (1972) and by Von Krosigk, et al., (1972); both groups 
reported significant progress after one generation of selection. 
Gyles and Brown, (1971) studied the effect of family selection on 
tumor regression induced by RSV. A closed population of chickens, 
initiated primarily by and F2 crosses between Arkansas Experiment 
Station strains of White Leghorn and Giant Jungle Fowl, was selected for 
regression of Rous sarcomas for six generations. Birds were challenged 
in the wing web with RSV at approximately six weeks of age, scored 
and observed weekly for size and regression of tumors. The percentage 
of birds inoculated that exhibited regression of tumors increased from 
14.3 to 59.2 and the percentage of tumors initiated that regressed 
increased from 18.2 to 63.7 over six generations of selection. 
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. MATERIALS AND METHODS 
Genetic Stock 
Inbred Lines 
Eight highly inbred lines, with inbreeding coefficients ranging from 
81% to 97% and segregating for eight different B locus alleles were used 
in this study. They were developed and maintained at the Poultry Research 
Center, Iowa State University, Ames, Iowa. Some of them have been closed 
since 1940 (Table 1). 
Line 8; A barred plumaged Leghorn about 91% inbred. Its origin is the 
same as lines 9 and 19 (Waters and Lambert, 1936). It segregates for the 
sex-linked barring gene, and the (I, i) dominant gene for white plumage 
color. In the 1950s it was maintained by mass mating for eight generations 
and since then has been pedigree mated (Marangu, 1970). Two B alleles, 
B^ and segregate. B^ was transferred from line SI and the B^^'^ 
is identical to the B^^'^ of line 9 (Somes, 1978). 
Line 9: A Leghorn line inbred to about 89% with forced segregation for 
plumage color. In 1956 line 9 was crossed to the Spanish line having 
black plumage and successively backcrossed six times to line 9 maintaining 
plumage color segregation (Smith and Nordskog, 1968). It is homozygous for 
the B^^'^ blood group allele. 
Line 19: A white Leghorn about 90% inbred originating from crosses 
tracing back to old Iowa State University inbreds maintained in the 1930s. 
It seems to be fixed for most blood group loci but segregates for three B 
alleles, B^, B^^ and B^ was transferred from line SI in 1973. 
Line GH: A white Leghorn about 90% inbred, originating from a commercial 
outbred strain (Ghostley). They are descendents of a female which had been 
accidentally mated to an HN male in 1958 producing progeny. An male 
was later mated to a line ffl female and also to two full-sibs so that back-
crosses and F2 progeny were obtained. In subsequent generations, matings 
were designed to maintain segregation at the B and C blood group loci 
(Schierman, 1962). This line has been used extensively in skin trans-
13 15 1 1 
plantation studies; three B alleles, B , B * and B , have been kept 
segregating. The latter is the same B^ allele found in the SI line. 
Line GHs; A subline of GH maintained since 1965 at the New York Medical 
College and later at the University of Georgia by Dr. L. W. Schierman. 
In 1976 a sample was returned to Ames. It segregates for two B alleles, 
B^ and (Trowbridge et al., 1978). 
Line HN: A white Leghorn line, about 97% inbred; originally obtained as 
a pure Kimber line from Heisdorf-Nelson in the early 1950s. It has been 
used for skin grafting experiments and segregates at the B blood group 
1 12 15 
locus. Three congenic lines with blood group alleles, B , B and B , 
were utilized for this study. B^ allele was transferred from line SI. 
Line SP: Spanish, a breed originating in Spain and brought to Iowa 
State in 1954, about 92% inbred. It segregates for two B alleles, B^ 
21 1 1 
and B ' . B allele was transferred from line SI. 
Line M; Fayoumi, a line derived from a breed of the same name imported 
from Egypt in 1949 primarily to test its resistance to lymphoid leukosis 
Y z 1 
disease. About 81% inbred, segregating for alleles B , B and B . 
Outbred line 
Outbred line SI produced from a cross of two Hy-line inbred lines in 
1964 (Nordskog, et al., 1973). It segregates for the blood group alleles, 
12 19 
B , B and B . A subpopulation of the SI line was subjected to 2-way 
selection for high and low antibody titer after inoculation with Salmonella 
pullorum bacteria (Pevzner et al., 1978). Within each genotype, 
2 2 19 19 
B B and B B , divergent selection for £. pullorum titer was continued 
over four successive generations. In the second generation, breeders 
were tested for immune response to GAT. The fourth generation progeny of 
the B^B^ genotype came from four mating types* Hi-Hi, Hi-Lo, Lo-Hi and 
Lo-Lo with respect to GAT response and S^. pullorum titer. In addition, 
B^B^ intermediate, B^^B^^-GAT-Hi and B^^B^^-GAT-Lo, were included in this 
experiment. Divergent selection for S. pullorum titer within these 
2 2 19 19 
genotypes did not prove successful. Thus, essentially all B B and B B 
birds used in this study were high (or "normal") responders to S^. pullorum. 
Heavy breed line 
Line W is a heavy-breed population synthesized from a cross between 
the Rhode Island Red and the Barred Plymouth from a cross in 1954. It is 
large in body size and has gold-barred plumage. This breed is highly 
resistant to lymphoid leukosis. In the summer of 1977, based on a pre­
liminary CAM test the line was divided into two sublines, WR and SW in 
an attempt to establish resistant and susceptible to RSV-subgroup A, 
respectively. At present this dichotomy, however, has been only partially 
successful. The WR and WS lines, estimated to have inbreeding coefficients 
of about 40%, have never been blood typed. These are brown-egg lines 
and may or may not carry distinctly different B locus &aplotypes. 
Virus strains. Purified stocks of RSV were used. Of practical 
significance is that the host range of RSV coincides with that of lymphoid 
leukosis viruses of the same subgroups. Moreover, RSV is easily assayed 
on the chorioallantoic membrane (CAM) (Vogt, 1965). Bryan high titer RSV 
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(BH-RSV) with Rous associated virus (RAV) were kindly supplied by Dr. L. 
B. Crittenden, RPRL, East Lansing, Michigan. The RSV-subgroups and 
dilutions of each used were 
Dilution 
Subgroup Pseudotype Abbr. ffu/ml^ Wingweb CAM 
A BH-RSV(RAV-l) RSV-1 IxlO^ 1-200 1-25 
B BH-RSV(RAV-2) RSV-2 5x10^ 1-400 1-50 
C BH-RSV(RAV-7) RSV-7 IxlO^ 1-100 1-15 
Wing web inoculation and tumor measurement. A total of .1,768 birds 
were inoculated in the subcutaneous tissue of the left wing web at 5 
weeks of age with a dosage of 0.05 ml per chick using a 26-gauge 3/4 
inch needle. All birds were examined once per week from the 7th to the 
70th day post-inoculation. Tumor response, induced by RSV, was scored on 
a scale ranging from zero (no tumor) to 6 (a massive tumor) as per Collins 
et al. (1977). Tumors developing within the intervals from 7 to 28!, 29 
to 49, and 50 to 70 days were designated arbitrarily as early, intermediate 
and late period, respectively (Gebriel et al., 1979). 
Chorioallantoic membrane inoculation and observations. A total of 
966 embryos were inoculated in the dropped chorioallantoic membrane (CAM) 
on the 12th day of incubation (Groupe et al., 1957). On the 19th day they 
were removed from the incubator and placed in a cold room at 2 to 4°C for 
observation in the following day. The inoculum consisted of 0.1 ml of a 
virus dilution tested to yield at least 100 pocks on the CAM's of suscep­
tible embryos. Pocks on the membranes were counted individually and 
^Focus forming units per ml. 
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classified as negative (no pocks) or as positive (> 0-25, 26-50, 51-75, 
and over 75 pocks). 
Terminology. The gene designations for cellular resistance-
susceptibility to the various Rous sarcoma subgroups and for tumor 
regression-progression are: 
Genes for cellular Genes for tumor 
Virus res/sue regr/progr 
subgroups Dominant Recessive Dominant Recessive 
RSV-A Tv-A® tv-A^ R-Rs-BT^ r-Rs-BT 
RSV-B Tv-B® tv-B^ R-Rs-BT r-Rs-BT 
RSV-C Tv-C® tv-C^ R-Rs-BT r-Rs-BT 
The designation for cellular res/susc follows that in the Biological 
Handbook III (Altman and Katz, 1979). The allelic designations, R-Rs-1 
and r-RS-1, as proposed by Schierman et al. (1977) designate a dominant 
regressor and a recessive progresser allele for locus 1. Their study was 
confined to the Schmidt-Rupin virus subgroup B. For simplicity we shall 
use "tv" and "rs" to designate, in general, any cellular res/susc locus 
and the tumor regr/progr locus, respectively. The existence of one B 
complex-linked locus which can be occupied by a series of alleles. In 
particular, I shall use R-Rs-12, r-Rs-1, and r-Rs-15 to designate one 
12 1 dominant and two recessive alleles linked, respectively, to the B , B , 
15 
and B blood group alleles. 
Statistical analysis. The data were analyzed by the Chi-squared test 
with a correction for continuity vrtien the criterion has a single degree of 
^Blood type. 
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freedom (Steel and Torrie, 1960). Gene frequencies (Table 2) were 
estimated for both the tv and rs genes by application of the Hardy 
Weinberg equilibrium law (Falconer, 1960). In particular, for a total 
of N birds inoculated with, say, virus subgroup A we define; 
np = number of progressors 
nr = number of regressors 
nt = np + nr = number developing tumors 
nf = number giving a negative response 
N = nt + nf = np + nr + nf 
The fraction, nf/N, represents the proportion of recessive birds of, 
V V 
say, the genotype, tv-A tv-A , which possess cellular resistance to RSV 
subgroup A infection. The estimated frequency of the tv-A^ gene is 
q = ^nf/N and that for the Tv-A^ allele is p = 1 - q. 
The fraction, np/nt, represents the observed proportion of birds 
of, say, the recessive genotype, (r-Rs)(r-Rs), which develop progressive 
tumors. The estimated frequency of the r-Rs gene is q' = -Jnp/nt and of 
the allele, R-Rs, is p' = 1 - q". These statements are summarized in Table 
2 which also shows the expected frequency of the 4 types of gametes in 
the population. Thus, the frequency of the double recessive gamete, tv-A^ 
r-Rs, is pq'. Note that: 
p + q = l = p '  + q '  a n d ,  t h e r e f o r e ,  
pp* + q'p = (p' + q") p = p and 
P'q  +  q 'q  =  (p*  + q*) q =  q  
Likewise; 
p'p + p'q = p' (p + q) = p' 
q'p + q'q = q' (P + q) = q' 
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Table 1. Homozygous B blood types derived from 8 inbred lines, one out-
bred line and heavy breed used in this study 
Line Breed Plumage 
Year 
of 
Origin 
% 
inbreeding 
1978 
Segregating 
Ea-B blood type 
8 Leghorn Barred 1940 91 B^and B^^'^ 
9 Leghorn Colored 1940 89 BlS.l 
19 Leghorn White 1940 90 B^, B^^ and B^^'^ 
GH Leghorn White 1954 90 B^, B^^ and B^^'^ 
GHs Leghorn White 1954 95 B^ and B^^ 
HN Leghorn White 1954 97 B^, B^^ and B^^ 
SP Spanish Black 1954 92 B^ and B^^*^ 
M Fayoumi Silver-penciled 1954 81 
1 y ? 
B , B and B 
SI Leghorn White 1962 Outbred B^B^-GAT-Lo 
B^B^-GAT-Hi 
2 2 
B B intermediate 
B^V^ GAT-Lo 
B^^B^^ GAT-fli 
WR Heavy- Red-barred 
breed synthetic 
1960 40 WR 
WS Heavy- Red-Breed 
breed synthetic 
1960 40 WS 
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Table 2. Expected frequency of cellular resistant (Tv) and tumor 
regression (Rs) genes 
Cellular susc/resist 
susc resist 
Tumor (Tv) (tv) Sum 
Progr (rs) pp' pq' p 
Regr (Rs) qp' qq' q 
~ Ï 
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RESULTS AND DISCUSSION 
Multiple Alleles at a Single Locus 
Linked to the B Complex 
Incidence of tumor response induced from wing web inoculation of 
RSV-A is given in Table 3. Presumably, part of the variation is due to 
sampling error, although differences in tumor regression among B complex 
genotypes are highly significant, statistically. For cellular resistance, 
the percentages ranged from 8.0 to 21.4 and from 10.0 to 24.0 in the first 
and second hatches, respectively. For tumor regression, the percentages 
ranged from 11.1 to 93.3 in the first and from 10.5 to 100.0 in the second 
hatches. The incidence of tumor response among B complex genotypes in 
the first hatch agrees closely with the results of the second, i.e., 14.8 
vs. 19.4%. Also the mean values of the homozygotes vs. heterozygotes 
genotypes were almost the same, i.e., 14.7 vs. 19.0%. For tumor regression, 
(Figure 1) the percentages were 51.0 and 42.5 for hatch I vs. hatch II, 
respectively, and 43.7 and 50.0 for homozygous vs. heterozygous genotypes, 
respectively. Differences among genotypes in cellular resistance were 
12 12 o 
within sampling errors. In tumor regression, B B was the highest (96.8%) 
and B^B^, B^^B^^, and B^B^^ had the lowest percentages (11.1, 15.8, and 
1 12 12 15 
14.6, respectively). The B B and B B genotype were intermediate 
(87.5 and 60.0%, respectively) 
Chi-squared differences among the six B complex genotypes over both 
hatches are presented in Table 4. Differences in cellular tesistance were 
not significant, but for tumor regression, B complex differences within 
both homozygous and heterozygous genotypes were highly significant. These 
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results verify findings reported by others (Schierman et al., 1977; 
Collins et al., 1977; Gebriel et al., 1979) that tumor regression, but 
not cellular resistance, is controlled by genes linked to the B complex. 
Table 5 and Figure 1 summarize the results showing mean differences 
among hatches, "zygotes" and genotypes in "progresser" tumor development. 
12 12 
For B B , 30 of 31 tumors proved to be regressors; only one was 
12 
classified as a progresser tumor. The allele linked to the B haplotype, 
designated R-Rs-12, is, therefore, a regressor gene. 
For B^B^, of 18 tumors, 16 were progressors and only 2 were regressors. 
Thirteen of the 16 tumors (81%) were formed in the early period. Thus, 
most B^ haplotypes carry a progresser gene r-Rs-1 which proved to be 
12 
almost completely recessive to R-Rs-12 of B , Thus, as expected for the 
1 1 9 
B B heterozygote genotype, 28 of 32 tumors were of the regressor type 
and only A were progressors. 
15 15 
For birds of the B B genotype, 32 of 38 tumors were progressors. 
15 
The B haplotype, therefore, carries a gene similar, if not identical to 
that linked to the B haplotype. However, 25 of the 32 progresser tumors 
(78%) were late developers in contrast to the B^B^ linked gene where 81% 
developed early. 
12 15 
Examination of the results of the B B heterozygous genotype reveals 
that 9 of 10 progressive tumors were late formers contrasting with the 
1 12 
B B heterozygotes where the 4 progresser tumors developed early. Thus, 
15 
it seems that the r-Rs-15 allele carried on B is similar to that carried 
1 12 
on B in that they both are recessive to R-Rs-12 linked to B except that 
the latter is incompletely dominant to r-Rs-15 but almost completely 
dominant to r-Rs-1. Also, as already noted, the B^^-linked allele produces 
28 
late developing progressive tumors and the B^-linked allele produces 
early developing progressive tumors. 
1 15 
Finally, a comparison of tumor expression of the B B heterozygote 
with the 2 corresponding homozygotes (B^B^ and B^^B^^) reveals that tumor 
expression of the B^B^^ heterozygote is essentially the same as the B^^B^^ 
homozygote, i.e., for B^B^^, 27 of 35 progressive tumors (77%) were late 
15 15 
developers and for B B , 25 of 32 (78%) were late developers. Thus, 
15 15 
late development, as expressed by the B B genotype, is seemingly 
dominant to early development as expressed by the B^B^ genotype. 
Table 6 presents the observed vs. the expected number of regressor/ 
progressor-type tumors formed in birds of the 2 heterozygous genotypes 
12 15 12 1 
B B and B B . The expected numbers are based on calculations using 
11 12 12 
allelic frequency estimations taken from the homozygotes B B , B B , 
and B^^B^^. The results demonstrate that the alleles linked to B^^, i.e., 
(R-Rs-12), and to B^, i.e., (r-Rs-1), behave essentially as a fully dominant 
2 
and recessive gene pair. The nonsignificant X test demonstrates that 
the observed ratio of regressor/progressor tumors agrees closely with 
12 15 
expectation. On the other hand, the allelic pair linked to B and B 
15 12 
demonstrates that the B -linked gene is not fully recessive to the B 
12 15 
linked allele. Thus, for the heterozygote B B in Table 3, we note that 
2 
the X for the combined hatches is highly significant, statistically. 
Therefore, the two alleles, respectively, linked to the B^ and B^^ 
12 haplotypes, are more or less recessive to the B -linked allele but differ 
one from the other. This leads us to deduce that the B complex-linked 
genes controlling tumor expression belong to a multiple allelic series. 
The consensus is that alleles existing in only 2 alternative states 
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are more the exception than the rule (Hartl, 1980). For tumor development 
genes determining sarcoma-leukosis resistance/susceptibility, however, only 
2 alleles are, so far, reported for susceptibility/resistance to virus 
subgroups A (Tv-A), C (Tv-C), and E (Tv-E). On the other hand, 3 
susceptible alleles and one resistant allele have been reported for 
virus subgroup B (Tv-B). It might be expected, therefore, that additional 
alleles should be discovered for RSV-induced tumor regression for each 
of the virus subgroups. 
The discovery of a distinct genetic mechanism linked to the B complex 
controlling tumor regression is rather recent (see literature cited in 
Introduction), although Gyles et al. (1968) was the first to suggest tumor 
regression was controlled by a single gene. Schierman et al. (19 77) 
proposed a nomenclature already used in mouse studies. He proposed R-Rs-1 
and r-Rs-1 as designations for a dominant regressor allele found in his 
line G-B2 and r-Rs-1 to designate a recessive progresser allele found in 
line G-Bl. It has been demonstrated by Trowbridge et al. (1978) and 
13 
in our laboratory that line G-Bl carries the B allele using a reference 
reagent standard proposed by an ad hoc committee and Schierman's line G-B2 
carries the B^ allele. It would seem useful, therefore, to relate these 
tumor regression genes to the B complex blood type to which they are linked. 
Thus, Schierman's R-Rs-1 and r-Rs-1 allelic pair might be more meaningfully 
designated R-Rs-6 and R-Rs-13. As already indicated, for the alleles 
linked to the B^, B^^, and B^^ complexes in this study, we propose the 
symbols r-Rs-1, R-Rs-12, and r-Rs-15. 
The simplest hypothesis of tumor regression control is that there 
exists an allelic series of multiple alleles at a single B complex-linked 
30 
locus. These alleles are assumed to respond more or less uniformly to 
tumors initially arising from Tv, tv susceptibility/resistance genes for 
all subgroup viruses (see Altman and Katz, 1979), 
An alternative, but more complex hypothesis, is that there exists a 
series of tumor regression loci, all linked to the B complex, each of 
which controls tumor expression uniquely for each of the tumor virus 
subgroups. A, B, C, etc. 
It is recognized that there may exist recombinant forms of B complexes. 
Thus, Gebriel et al. (1979) showed that genes for tumor expression are 
closely linked to the locus controlling immune response to GAT. In 
particular, they found that B^B^ GAT-Low birds were almost all progressors 
but progeny of B^B^ GAT-High matings contained both regressors and 
progressors. In this case, allelic designations would be R-Rs-1 and r-Rs-1 
implying that B^ haplogypes exist in recombinant form. More recently, 
Collins et al. (1980) demonstrated the existence of both regressor and 
2 2 
progresser type alleles linked to the B B complex. Nevertheless, the 
inclusion of the B blood type in a uniform nomenclature would be useful 
because of the tight linkages of tumor regression genes to the B complex. 
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Table 3. Tumor response from wing web inoculation of RSV subgroup A 
within B complex genotypes of the HN inbred line 
Cellular Resistance Tumor Regression 
B Complex No. No. No. No. 
Genotype Inoculated Negative % Tumors Regressors % 
First Hatch 
10 1 10.0 9 1 11.1 
12*12 16 1 6.3 15 14 93.3 
15B15 22 4 18.2 18 3 16.7 
25 2 8.0 23 21 91.3 
lBl5 28 6 21.4 22 4 18.2 
12b15 14 3 21.4 11 7 63.6 
Second Hatch 
10 1 10.0 9 1 11.1 
18 2 11.1 16 16 100.0 
26 6 23.1 20 3 15.0 
B^BlZ 11 2 18.2 9 7 77.8 
B^BlS 25 6 24.0 19 2 10.5 
18 4 22.2 14 8 57.1 
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Table 4. Chi square tests for significance of tumor response from 
wing web inoculation of RSV-A in HN inbred line over two 
hatches 
Source of Variance d.f. 
Cellular 
Resistance 
Tumor 
Regression 
Hatches 1 0.57 1.23 
Homozygous vs. heterozygous 1 0.47 1.73 
Hatch X "zygotes" 1 0.01 1.13 
Blood types (BT) within homozygotes 2 2.66 55.61** 
Blood types within heterozygotes 2 2.02 39.52** 
Hatch X BT within homozygous 2 0.13 3.16 
Hatch X BT within heterozygous 2 0.09 3.46 
< 0.01. 
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Table 5. Mean tumor response summarized by hatch, "zygotes" and 
serotypes 
No. No. 
Tumor 
Regression 
Tumor 
Progression 
Inoculated Tumor No. % Noi Early Inter. Late 
Summary by experiments» 
First hatch 115 98 50 51.0 48 12 6 30 
Second hatch 108 87 37 42.5 50 11 8 31 
Summary by genotypes: 
Homozygous 
genotype 102 87 38 43.7 49 15 9 25 
H eterozygous 
genotype 121 98 49 50.0 49 8 5 36 
Summary by serotypes: 
20 18 2 11.1 16 13 3 0 
Bl^BlZ 34 31 30 96.8 1 1 0 0 
48 38 6 15.8 32 1 6 25 
B^BlZ 36 32 28 87.5 4 4 0 0 
BlglS 53 41 6 14.6 35 4 4 27 
b12B15 32 25 15 60.0 10 0 1 9 
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Table 6. Observed vs. expected number of regressor- and progressor-type 
tumors formed in birds of the slZglS and B^Bl2 genotypes 
Type of Tumor and No. 
B Genotype Hatch 
Regressor 
Obs - ExpB 
Progresser 
Obs - Exp 
Total 
\ 
Preb. 
B^^B^ 1 21 - 19.1 2 - 3.9 23 0.60 .25<p<.50 
(R-Rs-12,^ 
r-Rs-1) 2 7 - 7.5 2 - 1.5 9 0.00 p 1. 
Combined 28 - 26.6 4 - 5.4 32 0.18 .5<p<,75 
1 7 - 9.1 4 - 1.9 11 1.63 .10<p<.25 
(R-Rs-12,^ 
r-Rs-15) 2 8 - 11.6 6 - 2.1 14 4.83 .025<p<,05 
Combined 15 - 20.75 10 - 4.25 25 7.82 .005<p<.01 
^Observed - Expected values. 
Expected number of progressors = qi qj Nij. 
, Expected number of regressors Nij = (1 - qiqj) Nij. 
Where: 
qi - calculated frequency of recessive allele (progresser) in 
Bifii genotype 
qj - calculated frequency of recessive allele (progresser) in 
genotype 
q - is estimated as ^ p/Nt and Np - is number of progresser 
tumors in genotypes B^B^ and B^BJ. 
^Putative alleles. 
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Tumor Development Tumor Regression 
B1 BI 
B12B12 
Bl Bis 
B12B15 
Homo 
Hetero 
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2nd. Expt. 
L 1 1 
100 80 60 40 20 0 0 
PERCENT 
20 40 60 80 100 
Figure 1. Tumor development and tumor regression from wing web 
inoculation of RSV-A in HN inbred line 
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Single Versus Multiple Loci 
Linked to the B Complex 
The results are presented in Table 7. The level of regression ranged 
from zero and 100%. Part of this variation, no doubt, is the result of 
incomplete gene penetrance and (or) other variable conditions of virus 
administration or individual bird variation not associated with genotype. 
2 
Table 8 presents a X analysis for both cellular resistance to tumor 
development (Tv, tv genes) and for tumor regression (R-Rs, r-Rs genes) 
between TSV subgroups A, B, and C (2 degrees of freedom). The results 
clearly demonstrate that for the Tv, tv loci, which are not linked to 
the B complex, differences between virus subgroups in tumor formation are 
13 13 
statistically significant in all cases at 0.01 level except for the B B 
genotype. In contrast, for the R-Rs, r-Rs locus controlling tumor 
regression, only 3 of 10 B complexes showed statistical significance. 
These were for B^B^, B^^B^^, and As already pointed out, the 
phenotypic level of tumor expression is probably dependent on total gene 
background. Also, because the results of each B complex represent an 
average over a variable number of lines, genetic background is not 
accurately controlled. Note that for combined data, differences between 
virus subgroups were not significant. Thus, the evidence suggests that a 
single locus hypothesis of tumor regression explains the variation in the 
data reasonably well. On the other hand, the fact that some of the 
2 individual X tests are statistically significant, leaves open the 
alternative possibility that loci linked to the B complex but unique to 
each RSV virus subgroup, control variation in tumor regression. 
Returning to Table 7, we divided the scale of percentage regressors 
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into 3 arbitrary classes: less than 25%, progresser (P); 25 to 75%, 
progressor/regressor (P/R); more than 75%, regressor (R). This gave the 
following distribution: 
RSV-A RSV-B RSV-C 
B^ B^  P p P 
- R R 
R R R 
P P/R P/R 
BI5.I3I5.I P/R P/R P/R 
B21.1B21.1 P/R - P 
BV P/R - P/R 
R - R 
WR P P P/R 
WS P/R P P/R 
1 
The results indicate that the B haplotype behaves as a progresser 
for all 3 virus subgroups, behaves as a regressor for B and C (A not 
12 13 
tested), B behaves as a regressor for all 3, B is questionable but 
15 1 21*1 
probably a progresser, B * is intermediate for all 3, B * is question-
Y Z 
able, but probably a progresser, B is intermediate on A and C, B is a 
regressor on A anc C, WR is probably a progresser, and WS is questionable 
but probably intermediate. Consistent results between RSV subgroups are 
1 1  12  1 2  
evidence for a single locus hypothesis as in the case of B B and B B 
Inconsistent results are evidence to reject the single locus hypothesis. 
Although, this analysis of the results is inconclusive, it seems that 
these are insufficient evidence to reject the single-locus hypothesis. The 
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classification of intermediate, or P/R, suggests that the observed 
tumor phenotype for a given B complex is dependent on total interacting 
background genes in the total genome. Also the possibility exists that an 
intermediate classification denotes multiple alleles. 
Table 7. Incidence of tumor expression induced by wing web inoculation of 
RSV subgroups A, B, and C 
B Blood 
Genotype 
RSV-A RSV-B RSV-C 
nr7nt^ ¥• nf/N • nr/nt nf/N nr/nt Reg. % 
B^B^ 11/78 13/67 19.0 39/69 7/30 23.0 20/69 1/49 2.0 
B^B* 28/28 - - 0/15 14/15 93.3 16/18 2/2 100.0 
BlZglZ 1/16 14/15 93.3 3/15 10/12 83.3 9/14 5/5 100.0 
28/86 9/58 15.5 27/52 9/25 36.0 15/53 17/38 44.7 
glS.lglS.l^g^gg 32/73 43.8 51/96 20/45 44.4 39/93 21/54 38.9 
b21.1B21. 2/26 15/24 62.5 27/27 - - 0/20 2/20 10.0 
aV 3/26 14/23 60.9 11/11 - - 1/18 7/17 41.2 
2/18 16/16 100.0 20/20 - - 12/25 10/13 76.9 
WR 12/16 1/4 25.0 15/16 0/1 0.0 7/16 7/16 33.3 
WS 10/15 2/5 40.0 14/16 0/2 0.0 7/22 5/15 33.3 
^nf = number giving a negative response. 
N = total number inoculated, 
4ir = number of regressors. 
4it = number with tumors. 
Reg. = regressors. 
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Table 8. Chi-squared tests for cellular resistance (Tv, tv genes) and 
for tumor regression (R-Rs, r-Rs genes) between RSV 
subgroups A, B, and C (wing web inoculation) 
Tv, tv expression Es expression 
X2 d.f. X2 d.f. 
26.9** 2 9.4** 2 
3*8* 52.2** 2 0.1 1 
13.l"* 2 1.4 2 
^ISBIS 7.4 2 10.3** 2 
BlS.lfilS.l 13.2** 2 0.4 2 
g21.1g21.1 65.3** 2 10.3** 1 
BV 36.9** 2 0.8 1 
EfBZ 30.7** 2 3.0 1 
WR 9.9** 2 0.5 2 
ws 12.4** 2 1.1 2 
Combined Data 76 .9^^ 2 6.7 2 
P < 0.01. 
40 
Role of B Complex Genotype in Cellular 
Resistance and Tumor Regression Mechanisms 
Cellular resistant (tv) loci 
Gene frequencies at the tv loci, estimated from both the CAM and WWC 
tests, are presented in Table 9 for the different inbred lines grouped 
according to B blood types in common. Based on the CAM test (Table 9A), 
differences in tv gene frequencies varied from 0 to 0.97. Chi square 
tests for line differences with B blood types in common were significant 
at P < 0.01 for all 3 virus subgroups. 
Turning to the WWC test (Table 9B), estimates of gene frequencies 
ranged from 0 to 1.0. Part of this variation is, no doubt, a consequence 
of incomplete penetrance, small numbers, and sampling errors. With the 
11 2 
exception of lines within B B blood type for RSV-A, the % differences for 
lines with common B blood types were significant at P < 0.01 for all 3 
subgroup viruses. 
Differences in cellular resistance (CR) among inbred lines ignoring 
blood types (IL/BT), were contrasted with differences among B blood types 
ignoring lines (BT/IL). For the CAM test (Figures 2 and 3), differences 
in CR among IL/BT was greater than among BT/IL. The range was 0 to 94.7% 
for the former and 0.38 to 0.89 for the latter. IL/BT differences were 
statistically significant for all 3 virus subgroups. Conversely, BT/IL 
were not statistically significant for subgroups A and C, although B was 
significant at the 5% level. 
The most highly resistant lines were GHS for RSV-subgroup A; lines 8, 
9, SP, and M for subgroup B; and lines 8, 9, and GHS for subgroup C. All 
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other lines were either susceptible or apparently were still segregating. 
These results support the studies reported by Collins et al. (1980) that 
the tv loci in general, maps outside the B complex. 
Reference to Figures (2 and 3) shows differences in CR ranging from 
0 to 1.0 for IL/BT but only from 0.38 to 0.84 for BT/IL. Statistical 
differences for the former were highly significant for all 3 virus sub­
groups but none were significant for the latter. The tv results from the 
WWC test were in good agreement with those from the CAM test. 
Correlations of tv gene expression for 2-way combinations for virus 
subgroups A, B, and C are presented in Table 10. The statistical evidence 
showing that tvc and tva loci are linked confirms the earlier findings of 
Dren and Pani (1977). 
Tumor regression (rs) loci 
Estimates of gene frequencies (p*) for lines with common blood types 
2 
IL/BT are given in Table 11. With one exception, x values are not 
statistically significant. This implies that genetic control, generally, 
does not reside outside the B complex. The exception is the group with the 
11 2 
B B blood types in common challenged with RSV-A (X = 25.00, d.f. = 5). 
In this case, the Fayoumi line M with 59% regressors (10/17) contrasts with 
the remaining pool of 5 lines of which 47 individuals are progressors and 
only 3 are regressors (6%). Thus, we have evidence that at least part of 
the genetic variance in tumore regression in the Fayoumi line may be con­
trolled by genes outside the B complex. 
The contrast of IL/BT in tumor regression, versus that between BT/IL 
is shown in Figure A. The highest percentages of tumor regressors were in 
lines 8, 9, and M and the lowest were in lines 19 and HN for RSV-A. In 
15 1 1 
addition the B * allele had the highest percentage and the B allele had 
the lowest percentage for tumor regression for subgroups A anc D. There­
fore, our results generally confirm those presented by Schierraan et al. 
(1977) and Collins et al. (1977) that rs genes are linked to the B complex. 
2 
Table 12 compares the magnitude of line variance (o^) within the 
2 
same B blood types, versus the variance of the mean B blood types, (o^) 
within the same lines for both the tv and rs loci. This permits a 
statistical measure of the relative importance of non-B versus B-linked 
2 2 genetic differences. The ratios, ^^re 3.2, 17.3, and 0.2 for the 
tv loci (CAM test), tv loci (WWC test), and for the rs loci (WW test), 
respectively. Thus, line variances were 3.2- and 17.3-fold larger than 
blood type variances based on the CAM and WWC tests for cellular 
resistance, respectively. In contrast, blood type variance was 5-fold 
larger than line variance for tumor regression. 
Correlation coefficients between the CAM and WWC tests, as calculated 
from the incidence of positive (or negative) reactions to total tests is 
given in Table 12. As expected, the correlations of the two tests for 
cellular resistance are high and positive ranging from 0,65 to 0.89. In 
contrast, the correlations of incidence of cellular resistance to 
incidence of tumor regression are lower and negative except for subgroup 
A (r = 0.42 and 0.12). These results support the two-locus hypothesis of 
resistance although cellular resistance and tumor regression are not 
wholly independent events. That is, they are gene frequency dependent. 
As an extreme example, differences in tumor regression can only be shown 
in birds which lack cellular resistance. 
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The "tv" results of this study support the hypothesis that cellular 
resistance to tumor viruses is controlled by single pairs of autosomal 
genes, that susceptibility is dominant to resistance, and that tva genes 
are linked to tvc but not to tvb in agreement with Pani and Biggs (1974). 
In addition, the results confirm those of Collins et al, (1977) and 
Schierman et al. (1977) that primary control of tumor regression rests with 
"rs" genes mapping in the B complex but that non-B complex rs genes may 
cooperate in tumor regression (Collins et al., 1980). 
An important question in the development and use of inbred lines 
relates to the residual heterozygosity after inbreeding. The expected 
probability of gene segregation (Q) decreases with inbreeding but also it 
is a function of the gene frequency in the line before inbreeding. In 
particular, 
Q = 2pq (1 - Ft) (1) 
where p and q are the allelic frequencies (p = q = 1), and Ft is Wright's 
inbreeding coefficient in generation t (Hartl, 1980). For example, consider 
line M with the lowest calculated inbreeding coefficient (F = 0.81) of 8 
lines (Table 1). The probability of segregation at locus tva is 
Q = 2(.5)(.5)(1 - .8) =0.9 assuming p = 0.5 = q. Conversely the proba­
bility of fixation is 1 - Q = 1 - 0.9 = 0.1. 
At the other extreme, line HN (Table 1) with the highest calculated 
inbreeding (F = 0.97), the expected Q at locus tva is .015. Thus, we 
expect the theoretical probability of heterozygosity remaining among the 
8 partially inbred lines in Table 1 for a given locus is in the approximate 
range of 1.5 to 10%. 
Furthermore, the number of lines all segregating at a given locus 
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should be binoraially distributed assuming the lines have independent 
origin. Consider n lines of vfliich r are segregating and n-r are fixed at, 
say, locus tva. For any one line, P is the probability of fixation and Q 
is the probability of segregation. Then the probability of n-r lines 
being fixed and r lines segregating at locus tva is CrP Q , where 
Cr = nî/(n-r)!rî 
For example, suppose we have 8 lines each with inbreeding coefficients 
of 80%; assume initial allelic frequencies at tva are P = 0.5 = q. Then 
substitution in formula (1) gives P = 0.9 and Q = 0.1. Expansion of the 
binomial (P + Q)" generates the following probabilities; 
Term Cr p"- Prob. 
p8 1 X .9» .43 
P^Q 8 X .9^ X 10"^ .38 
P^Q^ 28 X .9* X loT^ .15 
pSqS 56 X .9^ X 10-3 .03 
P^Q* 70 X .9^ X 10-4 .005 
P^Q^ 56 X .9^ X lO"^ .000 
P'q' 28 X .9^ X 10-* .000 
P 8 X .9 X 10-7 .000 
Q® 1 X 10-8 .000 
1.000 
Thus, the probability that all 8 lines are fixed at the same locus, 
as tva, is 0.43; the probability that only 1 line of 8 is segregating at 
tva is 0.38; that 2 lines are segregating is 0.15 and the probability that 
no more than 4 lines are segregating at tva is 0,995. 
For three loci, as tva, tvb, and tvc, the theoretical problem is more 
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complex but straightforward if the three loci are known to be independent 
or if their linkages are known. 
A perusal of the results reported here would suggest that the 
observed apparent segregation at both the tv and rs loci is greater than 
one would expect with coefficients of inbreeding in the observed range of 
our values 0.81 to 0.97. We, therefore, deduce that forces exist which 
retard the expected progress towards gene fixation. 
Abplanalp (in Altman and Katz, 1979) has discussed some of these 
forces and has pointed out that the chance for pedigree errors is con­
siderably greater in chickens than in mice. This comes about because a 
mouse litter naturally identifies with its mother, but with chickens, 
using modern artificial hatching and rearing, this cannot happen. In 
chickens, a single male is usually pen-mated to several hens; this may 
lead to errors in marking eggs, misreading numbers, chick mix-ups on 
hatching, and possibly other kinds of clerical errors. 
An important tool to minimize such errors and to maintain genetic 
purity is blood typing. Because this practice has been followed for the 
past several years in our laboratory, we believe we have been able to avoid 
pedigree errors. Therefore, we believe factors other than pedigree 
errors account for the maintenance of seemingly excessive heterozygosity 
in some of our lines. Of possible importance is natural selection and 
the greater fitness of the heterozygote. A second possibility is 
incomplete penetrance of a gene. Perhaps this rather vague concept is 
better interpreted in terms of nonuniform environmental effects. For 
example, two chickens of the same genotype may give different responses 
when treated with a given virus, because it is not possible to administer 
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exactly the same dose of virus particles to each. Moreover, the response 
mechanisms of two different chickens would not be the same because the 
overall immune mechanisms of each would differ in subtle ways depending 
on prior encounters with ubiquitous random environment and disease. 
This raises some question of the validity of estimation and use of 
allelic frequencies in data of this type. If penetrance of a gene is 
incomplete, or if its expression is influenced by nonuniform environmental 
effects, then gene frequency estimates may contain a bias. For example, 
if some genetically susceptible genotypes don't express the challenge 
expected from a dose of virus, they then would be misclassified as 
resistant. In a given test, let 
S = fraction of those tested which are truly susceptible 
R = fraction of those tested which are truly resistant 
a = fraction of susceptible genotypes not responding to challenge. 
An extimate of the allelic frequency of, say, the tva gene would be 
(assuming resistant allele is recessive); 
q(tva) = VR + a 
It follows that the estimated frequency p, of the allele Tva, is 1 - -JR + a.. 
Thus, when a > 0, q(tv) is biased upwards and p(tv) is biased downwards. 
Supposing that in a highly inbred line S = .9, R=0, and a = 0.1. Then, 
the estimated q(tv) = ^ 0 + 0.1 = .32 and p(Tv) - 1 - .32 = .68. Thus, 
incomplete penetrance or environmental effects, can seriously bias estimates 
of gene frequency. As a consequence, this situation will make it appear 
that segregation is greater than expected in a highly inbred line. 
This suggests that an analysis of the genetic basis of resistance 
to, say, RSV infection requires a quantitative approach. 
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Pani and Biggs (1974) estimated the heritability of genes controlling 
susceptibility of the chick embryo CAM to RSV infection. Their data, 
consisting of two parental lines, plus an F1 and an F2 population, 
clearly demonstrated a single pair of alleles controlling CAM foci 
development. One parent line was susceptible and the other resistant. 
Heritability was estimated as, 
h2 =0.71 
where the V's are variances of the F2, PI, and P2 (parental) populations. 
This estimate is in close agreement with an earlier study reported by 
Bower et al. (1964) of h^ = 0.72. 
Genetic variance is partitionable into additive and nonadditive 
fractions. When dominance is complete, i.e., the heterozygote is equal to 
the homozygous dominant, then the total genetic variance is partitionable 
2 2 into additive (aA ) and dominance deviation (aD ) fractions. Thus, 
h^ = (aA^ + aD^)/(oA^ + aD^ + CTE^) is referred to as heritability in the 
2 2 
broad sense (Lush, 1948). We deduce that aE = 1 - h = 0.30 is the 
estimated fraction of nongenetic variance associated with a CAM test, and 
perhaps also the WW test, for RSV susceptibility; accordingly, it serves 
as part of the explanation as to why several of the partially inbred lines 
tested in this study appear to be segregating for "both tv and rs loci 
greater than expected as judged by their inbreeding coefficients. 
2 
The estimate of h =; 0.71, as reported by Pani and Biggs (1974), is 
maximal because the allelic frequencies in the F2 population are equal 
to p = 0.5 = q. Thus, whenever allele frequencies differ, i.e., p # q, 
the genetic variance would be less than maximum. The general expression 
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is, (aA^ + aD^) = 2pq[a + (q - p)dj^ + (2pqd)^ where the first term is 
the additive fraction and the second the dominance fraction of genetic 
variance (Hartl, 1980). The "a" is the average effect of the gene substi­
tution and d is the dominance effect. When dominance is complete, a = d. 
2 2 
If a is set equal to 1, then aA = % and aD = %. In this case, the 
2 2 fraction of genetic variance, aA + aD , is equal to 3/4 of the total. 
This is maximal, as one might expect, in an F2 population. On the other 
2 2 hand, if gene frequencies are, say, p = 0.1 and q = 0.9, then oA + aD = 
2 
.58 + .03 = .61. Conversely, if p = 0.9 and q = 0.1, then aA = 0.1 and 
aD^ = .03. 
Obviously, when p or q = 1, then the total genetic variance is zero. 
2 
On the other hand, the nongenetic fraction of variance, ae , earlier 
alluded to, is generally assumed not to be influenced by changes in gene 
frequency. Thus, based on the Pani and Biggs (1974) study, we deduce that 
about 30% of the variance in our estimates of resistance/susceptibility is 
of nongenetic origin within the lines studied. 
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Table 9a. Chi squared test for significance of cellular resistance 
(tv) among inbred lines with common blood types to three 
Rous sarcoma virus subgroups. Data from CAM test 
RSV - A& RSV - B RSV - C 
Line nf/N q( tv) nf/N q(tv) nf/N q(tv) 
Blood type : B^B^ 
8 2/10 0.45 9/10 0.95 8/12 0.82 
19 2/25 0.28 2/20 0.32 1/15 0.26 
GH 0/11 0.00 5/11 0.67 1/11 0.30 
HN 1/11 0.30 1/10 0.32 6/11 0.74 
SP 0/10 0.00 7/11 0.80 0/10 0.00 
M 7/16 0.66 10/14 0.85 1/10 0.32 
for 5 d.f. 16.15"* 28 . 34** 24.98** 
Blood type .lgl5.1 
8 14/25 0.75 22/24 0.96 10/13 0.88 
9 9/20 0.67 18/19 0.97 10/14 0.85 
19 1/13 0.28 9/12 0.87 3/10 0.55 
GH 5/28 0.42 17/29 0.77 5/19 0.51 
y? for 3 d.f. 
irk 
13.88 12 
Blood type B 
.36''* 
I33I3 
12.20 
19 0/22 0.00 1/11 0.30 4/10 0.63 
GH 1/21 0.22 11/18 0.78 0/14 0.00 
GHs 17/21 0.90 0/18 0.00 12/17 0.84 
2 ^ 
X for 2 d.f. 34.32 19 .70** 
VwV 
16.24 
a Fraction of cellular resistant embryos to total number inoculated. 
Vnf/N = q(tv). 
•p < 0.01 
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Table 9b. Chi squared test for significance of cellular resistance 
(tv) among inbred lines with common blood types to three 
Rous sarcoma virus subgroups. Data from Wing Web challenge 
RSV-A* RSV - B RSV - C 
Line nf/N q(tv) nf/N q(tv) nf/N q(tv) 
Blood type : B^B^ 
8 
19 
GH 
HN 
SP 
M 
1/ 6 
6/23 
0/15 
1/10 
0/ 4 
3/20 
0.41 
0.51 
0.00 
0.32 
0.00 
0.39 
5/ 5 
10/20 
6/16 
1/10 
5/ 6 
10/10 
1.00 
0.71 
0.61 
0.32 
0.91 
1.00 
4/ 4 
0/16 
1/12 
8/17 
0/ 7 
7/13 
1.00 
0.00 
0.29 
0.69 
0.00 
0.73 
for 5 d.f. 6.18 24 
Blood type 
.42 
.I3I5.I 
27 .69** 
8 
9 
19 
GH 
6/16 
16/24 
1/19 
1/20 
0.61 
0.82 
0.23 
0.20 
15/15 
21/21 
7/17 
8/20 
1.00' 
1.00 
0.64 
0.63 
16/16 
18/18 
0/17 
0/20 
1.00 
1.00 
0.00 
0.00 
X^ for 3 d.f. 
ii>'' 
27.11 30 .75* 70.89** 
Blood type B 
13^13 
19 
GH 
ffls 
0/29 
0/29 
28/28 
0.00 
0.00 
1.00 
4/15 
16/20 
7/17 
0.52 
0.89 
0.64 
0/18 
2/19 
13/16 
0.00 
0.32 
0.90 
y} for 2 d.f. 86.05 10 .92** 32 .44** 
^Fraction of cellular resistant birds to total number inoculated, 
Vnf/N = q( tv) . 
Vf <v 
P < 0.01. 
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Table 10. Correlations of tv gene expression for 2-way combinations 
of virus subgroups 
CAM wwc Combined 
Correlation d.f. —> 6 6 12 
rAB -.07 .21 .09 
rAC .59 .71* .69** 
rBC 
CO 0
 1 .53 .37 
"P < 0.05. 
P < 0.01. 
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Table 11. Chi squared test for significance in tumor regression (rs) 
among inbred lines with blood types in common to three RSV 
subgroups. Data from Wing Web challenge 
RSV - RSV - B RSV - C 
Line np/nt p(rs) np/nt p(rs) np/nt p(rs) 
Blood type B^B^ 
8 4/ 5 0.11 - - - -
19 17/17 0.00 9/10 0.05 16/16 0.00 
GH 15/15 0.00 7/10 0.16 11/11 0.00 
HN 8/ 9 0.06 6/ 9 0.18 7/ 7 0.06 
SP 3/ 4 0.13 1/ 1 0.00 6/ 6 0.00 
M 7/17 0.36 6/ 6 0.00 
x^, (d.f.) 25.00'' (5) 2.01 (3) 4.63 (4) 
Blood 15.In 15.1 type B '^B 
8 4/10 0.37 - — - -
9 4/ 8 0.29 - - - -
19 12/18 0.18 2/10 0.55 9/17 0.27 
Œ C/19 0.44 3/12 0.50 8/20 0.37 
X^, (d.f .) 4.84 (3) 0 
Blood type 
.09 
B^^B 
(1) 
13 
0.63 (1) 
19 
GH 
GHs 
24/29 
25/29 
0.09 
0.07 
7/11 
2/ 4 
7/10 
0.20 
0.29 
0.16 
12/18 
7/17 
2/ 3 
0.18 
0.36 
0.18 
(d.f .) 0.14 (1) 0 .56 (2) 2.48 (2) 
^Fraction of number of progressors to total number with tumors, 
7np/nt - p. 
irit „ 
P < 0.01. 
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Table 12. Comparison of line variance (CT ) within blood types versus 
2 
variance of mean blood types (ffg) within lines for incidence 
of cellular resistance (tv) and tumor regression (rs) 
RSV-subgroups 
L i n e  A B C  Blood type 
2 
RSV-subgroups a among lines 
2 Qg among B's 
cellular resistance (CAM test)' 
8 0.46 0.91 0.72 B 0.09 0.39 0.26 
19 0.05 0.28 0.23 B15.1 0.30 0.74 0.43 
GH 0.10 0.57 0.14 Bl3 0.02 0.41 0.17 
X 0.20 0.59 0.36 X 0.14 0.51 0.29 
= 0.0617 aj = 0.0193 3.2 
cellular resistance (Wing Web Test) 
8 0.32 1.00 1.00 0.16 0.51 0.16 
19 0.10 0.40 0.00 B15.1 0.16 0.58 0.30 
GH 0.02 0.54 0.06 Bl3 0.15 0.58 0.30 
X 0.15 0.65 0.35 X 0.10 0.55 0.17 
o: = 0.1093 ct'  = 0.0063 
D 17.3 
8 0.53 
19 0.83 
GH 0.73 
X 0.70 
aj = 0.0120 
tumor regression (Wing Web Test)c 
- -
Bl 0.97 0.80 1.00 
0.58 0.73 B15.1 0.47 0.23 0.46 
0.46 0^.54 0.84 0.60 0.54 
0.52 0.64 X 0.76 0.54 0.67 
cjg = 0.0590 0.20 
^Fraction of cellular resistant embryos to total number inoculated. 
^Fraction of cellular resistant birds to total number inoculated. 
'^Fraction of number of progressors to total number with tumor. 
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Table 13. Correlations between the CAM tests and the WWfC test for 
expressions of cellular resistance and tumor regression 
RSV-subgroups 
Correlation ABC 
if't _ ** •}( 
rl2 0.89 0.70 0.65 
rl3 0.42 -0.06 -0.15 
r23 0.12 -0.53 -0.43 
Test 
1 CAM, cellular resistance 
2 WW, cellular resistance 
3 WW, tumor regression 
"P < 0.05, d.f. = 11. 
Vf-V 
P < 0.01. 
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Figure 2. Tumor development of different inbred lines ignoring 
B blood types at 70 day post-inoculation 
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Figure 3. Tumor development of different B blood types ignoring, 
lines at 70 days post-inoculation 
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Figure 4. Tumor regression at 70 days post-inoculation between 
inbred lines ignoring blood types, versus that between 
blood types ignoring lines 
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GENETIC LINKAGE BETWEEN IMMUNE RESPONSE TO GAT 
AND THE FATE OF RSV-INDUCED TUMORS IN CHICKENS 
Data In this section have been published in Immunogenetlcs 
9:327-334, 1979. 
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ABSTRACT 
Recent studies suggest that the gene locus controlling the fate of 
tumors induced by Rous sarcoma virus (RSV) is linked to the B histo­
compatibility complex. Birds carrying the dominant allele regress the 
tumor; homozygous recessives being unable to do so, develop large tumors 
and die. These are called progressors. 
The Bryan strain of RSV was inoculated into 220 6 week old Leghorns 
1 1 2  2  1 9  1 9  homozygous for B B > B B , or B B of which the percentages of progres­
sors were 79, 22 and 56, respectively. The balance of each were regressors 
and survived. 
The B^B^ test birds were derived from special matings, i.e., high and 
low immune responders to the amino acid polymer, GAT. Of 67 tests progeny 
of the B^B^ GAT-low mating, 63 or 94% proved to be progressors, and 6% were 
regressors. Of 84 test progeny of the B^B^ GAT-high matings, 67% were 
progressors, and 33% were regressors. The difference between the high and 
low GAT responders is highly significant and indicates that the locus 
controlling the fate of RSV-induced tumors is closely linked to the locus 
controlling immune response to GAT. The latter maps within the Ir region 
of the B histocompatibility complex. 
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INTRODUCTION 
Previous studies have reported evidence for genetic control of resis­
tance and susceptibility to infection frou Rous sarcoma virus (RSV) 
inoculation in young chickens (Waters and Burmester 1961, Crittenden et al. 
1964, Gyles et al. 1968). More recently Collins and co-workers (1977) 
and Schierman and co-workers (1977) demonstrated that genetic control of 
the fate of RSV tumors is closely linked to, or within, the B major histo­
compatibility complex. In addition, the Schierman group found that 
regression of RSV tumors, induced by the Schraidt-Ruppin strain of subgroup 
B, is determined by a dominant gene designated R-Rs-1^. The recessive 
allele, designated r-Rs-1^, permits uncontrolled (progressive) tumor 
growth in homozygous birds. Our study, reported herein, indicates that 
the RSV genes map within the Ir region of the B complex. In particular, 
we have found close linkage between the RSV genes, which control tumor 
regression to subgroup A RSV, and the immune response locus (Ir-GAT), which 
controls antibody production to the amino acid polymer, GAT^^ (Pevzner et 
al. 1978). 
^For convenience we use Rs and rs to designate resistant and suscep­
tible alleles, respectively. 
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MATERIALS AND METHODS 
Birds used in this study were 51 line Leghorns homozygous for alleles 
1 2 19 
B , B and B (Nordskog et al. 1973). A subpopulation of the 81 line 
was subjected to 2-way selection for high and low antibody titer after 
inoculation with Salmonella pullorum bacterin (Pevzner et al. 1977). Within 
11 2 2 19 19 
each genotype, B B , B B , and B B , divergent selection for pullorum 
titer was continued over four successive generations. In the second 
generation, breeders were tested for immune response to GAT. The fourth 
generation progeny of the B^B^ genotype came from four mating types: High-
High, High-Low, Low41igh and Low-Low with respect to GAT response and to 
2 2 19 19 
S. pullorum titer. In addition, B B and B B birds testing, respec­
tively, as intermediate and as high responders to GAT, were included in 
the experiment. Divergent selection for pullorum titer within these 
2 2 19 19 
genotypes did not prove successful. Thus, essentially all B B and B B 
birds used in this study were high (or "normal") responders to pullorum. 
Rous sarcoma virus (RSV) identified as avian RNA leukosis-sarcoma 
subgroup A RSV-1 Bryan strain, was kindly supplied by Dr. L. B. Crittenden, 
RPRL, East Lansing, Michigan. A total of 220 birds were inoculated in the 
subcutaneous tissue of the left wing web at 6 weeks of age with a 26-gauge 
3/4 in. needle. A dosage of 0.05 ml per chick with 1*200 dilution was used. 
All birds were examined once each week from the 7th to the 70th 
day post-inoculation. 
Tumor responses induced by RSV were scored for size on a scale 
ranging from 0 (no response) to 6 (massive tumor) following essentially the 
same procedure as given by Collins and co-workers (1977). Those developing 
from day 7 to 28, 29 to 49 and 50 to 70 days were arbitrarily designated 
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as early, intermediate and late periods, respectively. 
It will be desirable to make a clear distinction between "haplotype" 
and "genotype" as used in this paper. The former defines constitution of 
the gamete with respect to three loci which are believed to control (a) 
serological determinants (as the B blood group), (b) immune response to 
GAT, and (c) RSV-induced tumor response. "Genotype" will designate either 
the haplotypic composition of the diploid individual or, less specifically, 
only the serological blood type of a bird, as 
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RESULTS 
All birds tested gave an initially positive tumor response. These 
were classified as "regressor" or Vprogressor" in accordance with class­
ification used by others (Gyles et al. 1968, Schierraan et al. 1977, 
Collins et al. 1977). Birds of three blood types, B^B^ and B^^B^^ 
were classified into six genotypes on the basis of their immune response 
to GAT and their serum antibody titer to pullorum. Of a grand total 
of 220 birds inoculated, 75 (34%) were classed as regressors, and 145 
(66%) as progressors. Differences between the average results for the six 
genotypes (Table 1) were highly significant statistically. Average 
differences between the B genotypes and between the high-low immune 
response-to-GAT genotypes were highly significant, but were not between 
the high and low titer-to^S. pullorum genotypes. 
Table 1 also summarizes the tumor responses within each of the three 
B genotypes. The B^B^ had the lowest percentage of regressors: 21.2% 
2 2 
were regressors, and 78.8% were progressors. For the B B genotypes, the 
2 2 
percentages were almost exactly reversed. In general, the B B birds 
19 19 
were strong regressors, and the B B were intermediate with about 44% 
being regressor and 66% progresser. Differences were statistically 
significant (P < 0.01). 
Table 2 summarizes the tumor response from RSV virus inoculation into 
B^B^ birds, exclusively. The first part contrasts the GAT-low and GAT-high 
groups. Thirty-three percent of the latter, but only 6% of the former, 
were regressors. Correspondingly, the percentages of progressors were 
67.0% and 94.0%. The difference is highly significant. 
Table 2 also presents the contrast between the progeny of high and 
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low titer parents to pullorum. Differences were small and not statis­
tically significant. The conclusion is that the (RS,rs) locus controlling 
the fate of the RSV induced tumors, is closely linked to the Ir-GAT 
locus and therefore maps within or close to the Ir region of the B 
corapl ex. 
Three arbitrary post-inoculaticn periods of tumor development were 
1 1 
scored for average tumor size; this is presented in Figure 1 for the B B 
birds of both GAT-low responder parents and of GAT-high responder parents. 
For the regressor-type tumors, the GAT-high responders develop tumors most 
rapidly. On the other hand, tumor development was slower and more uniform 
throughout the test period for the GAT-low group. For the progressive-
type tumors, most of the GAT-low responders showed rapid development and 
those of the GAT-high responders, slower development. 
Scores for tumor development (Fig. IB) averaged around 2 for the 
regressor-type and between 5 and 6 for the progressor-type. Differences 
between periods and between GAT responders were small and not statistically 
significant. 
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Fig. lA and B. Tumor development classified by subgroups and initial 
period of development: Early (0-28 days). Intermediate 
(29-49) days and Late (50-70 days). Percentage of birds 
is given in (A) and average score is given in (B) 
66 
DISCUSSION 
The genetic mechanism involved in resistance to the leukosis/sarcoma 
viruses can be described in terras of a first and second line of defense 
(Crittenden 1975). The first is cellular resistance, i.e., a mechanism 
that prevents a virus from penetrating living host cells. Cellular resis­
tance is genetically controlled by single genes specific to each virus 
subtype. Thus, the tva locus controls resistance to subgroup A viruses 
with susceptibility being completely dominant to resistance. The second 
line of defense is a mechanism of genetic resistance to tumor development 
which comes into play after the virus has already penetrated the cell. 
The resistance mechanism seems to interfere in the reproduction of viral 
progeny such that the host develops an immunity which leads to, say, tumor 
regression. 
Collins and co-workers (1977) and Schierman and co-workers (1977) 
reported that regression of tumors induced by RSV A and B, respectively, 
is controlled by genes in the B complex. Because all the chickens inocu­
lated with RSV A virus in our study developed tumors, this indicates that 
they lacked cellular resistance. 
Genes coding for control of the fate of Rous sarcoma virus induced 
tumors are evidently closely linked to the Ir-GAT locus. Whether the former 
maps within the Ir region is indeterminate or until a marker gene is found 
which would define the limit of the Ir region in one direction (as Ss-
Slp in mice). For purposes of discussion, we assume the following linear 
order of regions and genes on the chromosome encompassing the B major 
histocompatibility complex: 
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Region SD Ir 
Genes B Ir-GAT Rs,rs 
The SD region may consist of two loci, as in the human HLA system, but 
in chickens this is not yet fully demonstrated. The Ir region includes 
the Ir-GAT locus and possibly also (Rs,rs). 
Birds classified as homozygous B^ genotype, based solely on the 
criteria of serological typing, may contain any pair-combination of the 
four haplotypes: 
Frequency 
in mating; 
No. 
I B 
Haplotype 
Ir(G-L) 
# 
rs 
Origin 
parental 
GAT-low 
P 
GAT-high 
P 
II B Ir(G-L) 
o 
Rs crossover 
III B Ir(G^l) rs crossover 
e .— 
IV Ir(G-H) Rs "parental" 
—• 1 *— 
Break point a P + Q = 1 
p + q + r+ s = l 
Haplotype I is assumed to be the typical or predominant haplotype origina 
originally found in the B^B^ blood groups of our SI line. Assuming that 
haplotype IV was derived as a crossover at break point a from matings of 
1 19 
B B heterozygotes, i.e.. 
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Ir(G-L) 
, we hypothesize the formation 
B Ir(G-H) Rs 
1 19 
of haplotypes II and III. Such recombinants involving both B and B 
are likely to have occurred with low frequency; those with superior fitness 
qualities may have accumulated over the many years of special matings in 
the 81 line (Nordskog et al. 1973) at the expense of those with low fitness 
through natural selection. 
The frequencies of the four haplotypes in the two special matings of 
the SI population (Table 2) depends on the amount of chromosome breakage 
at b, which in turn depends on the tightness of linkage between the two 
adjacent loci as well as on the composition of the particular sample of 
breeders selected for each mating. 
A unique feature of the data is that GAT response was measured only 
in the parental generation and RSV tumor response was measured only in the 
progeny generation. This was not only a matter of expedience but also it 
seemed unwise to test for GAT response in the progeny as this might 
interfere with the tests for tumor response. At the same time, this 
experimental design does not invalidate the estimation of gene frequencies 
(and haplotype frequencies) by application of the Hardy-Weinberg equili­
brium law (Falconer 1960. A special theorem of the Hardy-Weinberg law is 
that gene frequency equilibrium is completely reached in the first progeny 
generation irrespective of the parental genotypic (or haplotypic) composi­
tion. Furthermore, the expected gene frequencies in the progeny will be 
the same as that in the selected sample of parental breeders. 
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Frequency of Haplotypes of GAT-low Matings 
Only haplotypes I and II would be involved in GAT-low matings assuming 
that Ir(G-L) is recessive to Ir(G-H). The frequency of haplotype I in 
the test progeny is then estimable from application of the Hardy-Weinberg 
principle. From Table 2 we set P = ^ .94 = ,97 and Q = 1 - P = .03. Thus, 
we deduce, that the frequency of the parental haplotype I in the GAT-low 
matings is 97% and that of the crossover haplotype, II, is 3%. This 
hypothesis accounts for the 6% of regressor progeny found in the GAT-low 
ma tings. 
Frequency of Haplotypes in the GAT-high Matings 
Breeders in the GAT-high matings could consist of any combination of 
the four haplotypes except l/l, l/ll or II/II. Because haplotype IV 
is recently derived and the frequency of crossover haplotypes II and III 
should be low, most of the breeders in the GAT-high matings are expected 
to be the heterozygote, I/IV. 
From Table 2 the frequency of progressors would consist of 
P^;I, I+2pr:I, Ill+r^sIII, III=.667 
Assuming that the frequency of crossover haplotype III is the same as for 
crossover haplotype II, we can solve for p, 
r=Q=.03 and Q=q. 
2 2 
Thus, p + 2p(.03) + (.03) = .667 and p = .79, the frequency of haplotype I. 
For haplotype IV, 
s = 1 - :79 - .03 - .03 = .15. 
In summary, based on the presented, the estimated haplotypic frequen­
cies of the progeny of the GAT-low and GAT-high matings are as follows: 
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Tested Frequency of haplotypes 
progeny 
Mating N I II III IV Total 
freq. P q r s 
GAT-low 67 .97 .03 - - 1.00 
GAT-high .79 .03 ^03 .15 1.00 
Combined 151 .87 .03 .02 .08 1.00 
From the combined estimates based on a weighted average of the two 
separate mating groups, and applying the Hardy-Weinberg law, we predict 
2 2 
that the overall mean percentage of progressors is lOOp = 100(.87 + .03) 
= 81%. This compares with the observed percentages (Table 2) of 78.3 and 
79.4, respectively, for the S^. pull.-low and S^. pull.-high groups and fully 
accounts for the nonsignificant effect of pullorom antibody titer on the 
fate of RSV-induced tumors. 
In addition to the four haplotypes proposed for the blood group 
in our SI population, we hypothesize a "parental" haplotype 
19 
^ k ^ — for the blood group with possible 
recombinant haplotypes resulting from crossovers at a and b. Likewise, 
2 2 for out B B blood group, the typical haplotypes is tentatively defined as 
B^ Ir(G-INTERMEDIATE)Rs. The GAT allele in the Ir region is probably 
1 19 
different from the GAT-Low and GAT^îigh alleles common to the B and B 
blood groups. 
Map Distance 
The estimate of 3% for each crossover haplotype II and III, should not 
be construed as an estimate of map distance between the GAT locus and (Rs, 
rs). Rather, the 3% is presumed to represent the net accumulation of cross­
over haplotypes over a period of many years. Crossing over has been 
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enhanced by deliberately maintaining forced heterozygosity of B blood 
groups over 10 or more years in the SI line (Nordskog et al. 1973, 1977). 
Furthermore, we assume that the MHC in the SI line is in linkage disequi­
librium. Thus, the accumulation of recombination haplotypes should 
continue each successive generation but at a progressively slower rate 
until linkage equilibrium is reached. A crude estimate of map distance 
between GAT and (Rs,rs) is .03/10 S .3 of 1% crossover units. Thus, it 
would seem reasonable to speculate that (Rs,rs) is located in the Ir 
region of the MHC. 
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Table 1. Tumor response from inoculation of RSV in six different B 
complex genotypes 
B complex No. Regressor Progresser 
inoculated Negative No. % No. _% 
B^B^ GAT-low S.P.-low 37 0 1 2.7 36 97.3 
B^B^ GAT-low S.P.-high 30 0 3 10.0 27 90.0 
B^B^ GAT-high S.P.-low 46 0 17 37.0 29 63.0 
B^B^ GAT-high S.P.-high 38 0 11 29.0 27 71.0 
B^B^ GAT-intermediate 37 0 29 78.4 8 21.6 
19 19 
B/^B GAT-high 32 0 14 43.8 18 56.2 
= 58.19 d.f. = 5 P < 0.01 
Summary by serotypes: 
B^B^ 151 32 21.2 119 78.8 
B^B^ 37 29 78.4 8 21.6 
32 14 43.8 18 56.2 
220 75 145 
= 44.50 d.f. =2 P < 0.01 
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Table 2. Summary of tumor response from inoculation of RSV of B B birds 
classified according to immune response to GAT and to pullorum 
titer 
Classification No. Regressor Progresser 
of breeder Progeny 2 
population Inoculated No. % No. % x d.f. P 
GAT-low 67 4 6.0 63 94.0 16.71 1 < 0.01 
GAT-high 84 28 33.3 56 66.7 
151 32 119 
S. pull.-low 83 18 21.7 65 78.3 0.025 1 N.S. 
S. pull.-high 68 14 20.6 54 79.4 
151 32 119 
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SUMMARY 
The genetic mechanism for cellular resistance/susceptibility to 
tumor formation in chickens after challenge with Rous sarcoma virus (RSV) 
is known to be largely, if not entirely, independent of the B major 
histocompatibility complex. Moreover, specific loci control resistance 
to each virus subgroup, A, B, and C. However, C is closely linked to A 
but not to B. A distinctly separate genetic mechanism linked to the B 
complex controls tumor regression/progression. This mechanism comes into 
play for chickens which are genetically susceptible to tumor formation. 
Tests were based on both wing web-challenge (WWC) on 5-week-old chicks 
and on the chorioallantioc membranes of 12-day embryos (CAM test). The 
absence of tumor development on WWC and of pock formation on CAM indicated 
cellular resistance to RSV (first line of genetic resistance). In 
addition, in WWC the differential response of tumors with respect to 
regressive or progressive tumor growth measured the second line of genetic 
resistance. 
1 1  1 2  1 2  
A comparison of tumor expression of the homozygotes, B B , B B , and 
BIS^IS demonstrates that the genes linked to B^^ and to B^ behave essen­
tially as a fully dominant/recessive allelic pair. On the other hand, the 
12 15 
allelic pair corresponding to genes linked, to B and B indicates that the 
former is incompletely dominant. Moreover, the two alleles, respectively, 
1 1 5  1 2  
linked to the B and B haplotypes, more or less recessive to the B 
linked allele, but differ distinctly one from the other. These results, 
therefore, indicate that the B complex-linked genes, controlling tumor 
expression, belong to a multiple allelic series at a single B complex 
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linked locus. 
On addition, the data were not decisively conclusive with respect to 
a single locus or a multiple locus hypothesis but the former gives a 
reasonably satisfactory fit to the data. For the 10 genetic subgroups 
marked with different B locus blood groups, 3 gave statistically significant 
differences in tumor regression between virus subgroups and 7 did not. 
This is evidence for multiple loci. On the other hand, combining the 
results over the 10 groups, again with 2 degrees of freedom, the differ­
ences were not statistically significant. This is evidence for the 
alternative hypothesis of a single B complex-linked locus controlling 
tumor regression. 
The results from both the WWC and CAM tests concluded that the tv 
loci for cellular resistance maps outside the B complex. In addition, 
the statistical evidence verifies the earlier findings that tva and tvc 
loci are linked. As expected, most of the variation in tumor regression 
in susceptible birds was linked to the B complex. An exception was the 
finding of significance between six inbred lines with the B^B^ blood 
type in common when challenged with RSV-A. Thus, part of the genetic 
variation in tumor regression may be controlled outside the B complex. 
In general, these results support the two locus hypothesis of resistance, 
although cellular resistance and tumor regression are not wholly independent 
events. Also, the results suggest that the observed apparent segregation 
at both the tv and rs loci is greater than expected in view of the high 
coefficients of inbreeding in our inbred lines. This is thought to be 
a consequence of natural selection and the greater fitness of the hétéro­
zygote and of incomplete gene penetrance. 
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Finally, the difference between the high and low GAT responders of 
test birds is highly significant. It indicates that the locus 
controlling the fate of RSV-subgroup A induced tumors is closely linked 
to the locus controlling immune response to GAT and therefore maps within 
or close to the Ir region of the B complex. 
78 
GLOSSARY OF TERMS 
Alloantigens: Different (allelic) forms of an antigen coded for at the 
same gene locus in all individuals of a species. E.g., 
histocompatibility antigens are coded for at the same locus 
but between individuals. 
Alloantiserum: An antiserum directed against antigens of another animal 
of the same species and raised in that species. E.g;, 
a serum made in one inbred strain of a species against 
another inbred strain of the same species. 
B lymphocytes: Lymphocytes that are derived from bone marrow without 
passing through the thymus. In birds, B lymphocyte 
maturation is determined by the bursa of Fabricius. 
B lymphocytes play a major role in humoral immunity. 
Bacterin: Vaccines consisting of suspension of bacterial cells that 
have been killed by chemical or physical means. E.g., 
Salmonella pullorum bacterin used as antigen in immune response 
reaction. 
Blood group: Classification of isoantigens on the surfaces of erythro­
cytes. The most important blood group in chicken is B blood 
group system. This system now knows as the major histo­
compatibility complex or the B complex in the chicken. 
CMI; Cell-mediated immunity, specific immunity which is dependent upon 
the presence of T lymphocytes. It is responsible for reactions such 
as allograft rejection, delayed hypersensitivity and is important 
in defense against viral infections. 
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Challenge; Administration of a virulent pathogen, e.g. in order to test 
initial immunity or the degree of protection achieved by 
treatment. 
Congenic lines; Possessing identical genotypes except for a single 
difference. Those are useful for studies of genetic 
differences in the major histocompatibility complex. 
GAT; Amino acid polymer, an antigen consists of L-glutamic acid^^, L-
alanine^^ and L-tyrosine^^. It is useful in immune response assay. 
GVH; Graft-versus-host reaction, is a reaction of a graft rich in 
immunologically competent cells, against the tissues of a genetically 
non-identical recipient. The recipient is unable to reject the 
graft. It can be induced by immune immaturity, immunosuppression, 
or differences in genetic constitution (i.e., hybrid). 
2 h : Heretability, a method used in selection to estimate the ratio of 
additive genetic variance to total phenotypic variance, VA/VP. 
H-2; The major histocompatibility complex in the mouse. H-2 genes 
determine the major histocompatibility antigens on somatic cell 
surfaces and also the immune response of the animal (Ir genes). It 
is composed of five regions; K, I, S, D, and G. 
H antigens; Histocompatibility antigens; the antigens responsible for 
tissue compatibility are designated as histocompatibility 
antigens and the genes coding for these structures are 
called histocompatibility genes (H genes). 
Haplotype; Set of genetic determinants coded by closely linked genes on 
a single chromosome. 
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IR region: The immune response region of B-complex of chicken which is 
responsible for stimulating specific immune response against 
any foreign antigen. 
IR gene(s); The immune response gene(s) located in immune response region 
of B-complex. 
Inbred line: Experimental animals produced by sequential brother-sister 
matings. In immunology, the terra usually refers to animals 
in the 20th and subsequent generations of such matings. Such 
animals are so homogeneous at histocompatibility loci. 
Inoculation: In immunology refers to introduction of a substance into 
the body, usually but not exclusively by parenteral injection. 
LLV: Lymphoid Leukosis virus; it is an avian, disease and is caused by an 
RNA myxo virus which affects almost any body tissue of a chicken 
producing tumors. 
MD: Marek's disease; it is an avian disease and is caused by a DNA herpes 
virus typically leading to cancer of the nervous tissues. 
MHC: Major histocompatibility complex; it codes for the cell membrane 
proteins which contain the major histocompatibility antigens. It is 
divisible into various regions on the basis of crossover analysis. 
Some species designations include: Ag-B in rat, B in chicken, H-z 
in mice and H LA in man. 
MLR: Mixed lymphocyte reaction; mixed culture of lymphocytes from two 
donors and resulting in cellular proliferation if nonidentical at 
the MHc. 
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RSV: Rous sarcoma virus; it is a defective virus which is unable to 
infect a cell except with the help of an Rous associated virus (RAV) 
Because the host range of RSV coincides with that of LLV of the 
same subgroup, RSV artificially-induced tumors using Rous sarcoma 
virus is a useful model to study body defenses against oncogenecis. 
SD; Serologically defined; blood cell antigens defined by the use of 
specific antisera. 
Titer; In serological reaction, a measure of the amount of antibody in 
an antiserum per unit volume of original serum. 
Tumor enhancement; An increased rate of tumor growth in animals immunized 
with the antigens of the tumor of injected with dilution 
of specific virus induced tumors. 
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APPENDIX 
Data from each inbred line have been listed 
in the next tables. 
Table 14. Tumor response from inoculation of RSV-subgroups A, B and C between B complex alleles 
of line M. 
B Complex Total No. Negative Regressor Progresser 
Allele Inoculated No. % No. % No. % 
RSV - A 
BV 26 3 11.5 14 53.9 9 34.6 
B^B^ 18 2 11.1 16 88.9 0 0.0 
B^B^ 20 3 15.0 10 50.0 7 35.0 
B^B^ 25 4 16.0 13 52.0 8 32.0 
25 4 16.0 21 84.0 0 0.0 
RSV - B 
bV 11 11 100.0 0 0.0 0 0.0 
B^B^ 20 20 100.0 0 0.0 0 0.0 
bV 10 10 100.0 0 0.0 0 0.0 
B^B^ 8 8 100.0 0 0.0 0 0.0 
B^B^ 11 11 100.0 0 0.0 0 0.0 
RSV - C 
BV 18 1 5.6 7 38.9 10 55.5 
B^B^ 25 12 48.0 10 40.0 3 12.0 
B^B^ 13 7 53.8 0 0.0 6 - 46.2 
B^B^ 5 0 0.0 3 60.0 2 40.0 
B^B^ 7 3 42.9 3 42.9 1 14.2 
Table 15. Tumor response from inoculation of RSV-subgroups A, B and C of lines WR and WS 
Total No. Negative Regressor Progresser 
Line Inoculated No. % No. % No. % 
RSV - A 
WR 16 - 12 75.0 1 6.3 3 18.7 
WS 15 10 66.7 2 13.3 3 20.0 
RSV - B 
WR 16 15 93.8 0 0.0 1 6.2 
WS 16 14 87.5 0 0.0 2 12.5 
RSV - C 
WR 16 7 43.8 3 18.8 6 37.4 
WS 22 7 31.8 5 22.7 10 45.5 
Table 16. Tumor response from inoculation of RSV-subgroups A, B and C between B complex alleles 
of lines 8 and 9 
Line B Complex Total No. Negative Regressor Progrèssor 
Allele Inoculated No. % No, % No. % 
RSV - A 
9 24 16 66.7 4 16.7 , 4 16.6 
8 slS.lglS.l 16 6 37.5 6 37.5 4 25.0 
B^B^ 6 1 16.7 1 16.7 4 66.6 
RSV - B 
9 21 21 100.0 0 0.0 0 0.0 
8 15 15 100.0 0 0.0 0 0.0 
B^B^ 5 5 100.0 0 0.0 0 0.0 
RSV - C 
9 18 18 100.0 0 p.O 0 0.0 
8 gl5.1gl5.1 16 16 100.0 0 0.0 0 0.0 
B^B^ 4 4 100.0 0 0.0 0 0.0 
Table 17. Tumor response from inoculation of RSV-subgroups A, B and C between B complex alleles 
of line 19 
B Complex 
Allele 
Total No. 
Inoculated 
Negative 
No. % 
Regressor 
No. 7. 
Progresser 
No. % 
RSV - A 
glS.lglS.l 
BV 
B^B^^ 
BlS.lglS.l 
B^V" 
B^B^ 
BV^ 
19 
29 
23 
12 
14 
17 
15 
20 
12 
12 
1 
0 
6 
6 
2 
5.3 
0.0  
26.1 
50.0 
14.3 
RSV - B 
7 41.2 
4 26.7 
10 50.0 
4 
3 
33.3 
25.0 
6 
5 
0 
0 
1 
8 
4 
1 
5 
2 
31.6 
17.2 
0.0 
0.0 
7.1 
47.1 
26.7 
5.0 
41.7 
16.7 
12 
24 
17 
6 
11 
2 
7 
9 
3 
7 
63.1 
82.8 
73.9 
50.0 
78.6 
11.7 
46.5 
45.0 
25.0 
58.3 
Table 17 continued. 
B Complex 
Allele 
Total No. 
Inoculated 
Nega tive 
No. % 
Regressor 
No. '/. 
Progresser 
No. % 
RSV - C 
glS.lglS.l 
bS13 
17 
18 
16 
12 
24 
0 
0 
0 
0 
1 
0 . 0  
0.0  
0.0 
0.0  
4.2 
8 
6 
0 
4 
5 
47.1 
33.3 
0.0 
33.3 
20.8 
9 52.9 
12 66.7 
16 100.0 
8 66.7 
18 75.0 
Table 18. Tumor response from inoculation of RSV-subgroups A, B and C between B complex alleles 
of line GH 
B Complex Total No. Negative Regressor Progrèssor 
Allele Inoculated No. % No. % No. % 
RSV - A 
b15.1B15.1 20 1 5.0 13 65.0 6 30.0 
29 0 0.0 4 13,8 25 86.2 
15 0 0.0 0 0.0 15 100.0 
RSV - B 
Bl5.1gl5.1 20 8 40.0 9 45.0 3 15.0 
gl3gl3 20 16 80.0 2 10.0 2 10.0 
BV 16 6 37.5 3 18.8 7 43.7 
RSV - C 
BlS.lfilS.l 20 0 0.0 12 60.0 8 40.0 
B^V^ 19 2 10.5 10 52.6 7 36.9 
bV 12 1 8.3 0 0.0 11 91.7 
Tablé 19, Tumor response from inoculation of RSV-subgroups A, B and C between B complex alleles 
of line GHs 
B Complex Total No, Negative Regressor Progresser 
Allele Inoculated No. % No, % No. % 
RSV - A 
B^^B^^ 28 28 100.0 0 0.0 0 0.0 
bV 28 28 100.0 0 0.0 0 0.0 
RSV - B 
17 7 41.2 3 1Z.6 7 41,2 
B^B® 15 0 0,0 14 93,3 1 6.7 
RSV - C 
16 13 81,2 1 6,3 2 12,5 
bV 18 16 88,9 2 11,1 0 0.0 
Table 20 . Tumor response from inoculation of RSV-subgroups A, B and C between B complex alleles 
of line HN 
B Complex 
Allele 
Total No. 
Inoculated 
Negative 
No. % 
Regressor 
No. % 
Progresser 
No. % 
B^BlZ 
B^5B15 
B^B^ 
B^B^^ 
B^BlZ 
Bl^BlZ 
b^B^ 
BV^  
BV^ 
22 
16 
10 
14 
28 
25 
23 
15 
10 
6 
13 
8 
22 
14 
17 
6 
11 
6 
4 
1 
1 
3 
6 
2 
0 
3 
1 
2 
2 
0 
5 
9 
8 
2 
6 
3 
RSV - A 
18.2 
6.3 
10.0 
21.4 
21.4 
8.0  
RSV - B 
0.0 
20.0 
10.0 
33.3 
15.4 
0 .0  
RSV - C 
22.7 
64.3 
47.1 
33.3 
54.5 
50.0 
3 
14 
1 
7 
4 
21 
3 
10 
3 
4 
3 
7 
1 
5 
1 
3 
0 
3 
13.6 
87.5 
10.0 
50.0 
14.3 
84.0 
13.0 
66.7 
30.0 
66.7 
23.1 
87.5 
4.5 
35.7 
5.9 
50.0 
0.0 
50.0 
15 
1 
8 
4 
18 
2 
20 
2 
6 
0 
8 
1 
16 
0 
8 
1 
5 
0 
68.2 
6 . 2  
80.0 
28.6 
64.3 
8.0 
87.0 
13.3 
60.0 
0.0 
61.5 
12.5 
72.8 
0.0  
47.0 
16.7 
45.5 
0.0 
Table 21. Tumor response from inoculation of RSV-subgroups A, B and C between B complex alleles 
of line SP 
B Complex 
Allele 
Total No. 
Inoculated 
Negative 
No. % 
Regressor 
No. 3 
Progressor 
No. % 
321.1321.1 
B^B^ 
BV^-^ 
b21.1B21.1 
b^B^ 
bV^-1 
b21.1B21.1 
B^B^ 
BI32I.I 
26 
4 
30 
27 
6 
15 
20 
7 
. 6 
RSV - A 
2 7.6 
0 0 .0  
4 13.3 
RSV - B 
27 100.0 
5 83.3 
14 93.3 
RSV - C 
0 
0 
0 
0.0 
0.0 
0.0 
15 
1 
16 
0 
0 
1 
2 
0 
0 
57.7 
25.0 
53.4 
0.0 
0.0 
6.7 
10.0 
0.0 
0.0 
9 
3 
10 
0 
1 
0 
34.7 
75.0 
33.3 
0.0 
16.7 
0.0 
18 90.0 
7 100.0 
6 100.0 
Table 22. Percentage of pock count on chorio-allantoic membranes (CAMs) from inoculation of RSV-
subgroups A, B and C between B complex alleles of line GH 
B Complex 
Allele 
No. 
Embryos 
% Pock Counts 
0 1-25 26-50 51-75 76+ 
RSV - A 
28 17.9 14.3 7.1 14.3 46.4 
21 4.8 9.5 9.5 4.8 71.4 
11 0.0 0.0 0.0 
RSV - B 
9.1 90.9 
b15.1J15.1 29 58.6 13.8 17.2 3.5 6.9 
B»B" 18 61.1 11.1 16.7 5.6 5.5 
BH^ 11 45.5 0.0 9.1 
RSV - C 
9.1 36.3 
19 26.3 10.5 10.5 15.8 36.9 
B"B" 14 0,0 14.3 7.1 14.3 64.3 
BV 11 9.1 9.1 0.0 9.1 72.7 
Table 23. Percentage of pock count on chorio-allantoic membranes (CAMs) from inoculation of RSV-
subgroups A, B and C between B complex alleles of line GHs 
B Complex No. % Pock Counts 
Allele Embryos -Q 26-50 5Ï775 76+ 
RSV - A 
21 81.0 14.3 4.7 0.0 0.0 
B*B^ 13 84.6 15.4 0,0 0.0 0.0 
RSV - B 
B^\^^ 18 • 0.0 0.0 11.1 22.2 66.7 
B*B^ 12 16.7 33.3 25.0 16.7 8.3 
RSV - C 
B^^B^^ 17 70,6 5.8 11.8 0.0 11.8 
B*B* 11 72.7 9.1 9.1 9.1 0.0 
Table 24. Percentage of pock count on chorio-allantoic membranes (CAMs) from inoculation of RSV-
subgroups A, B and C between B complex alleles of line SP 
B Complex 
Allele 
No. 
Embryos 
% Pock Counts 
1-25 26-50 51-75 76+ 
b21.1B21.1 
BH^ 
b21.1B21.1 
B^B^ 
B21.1g21,l 
BS^ 
22 
10 
20 
II 
14 
10 
27.3 
0 .0  
85.0 
63.6 
0.0  
0 . 0  
31.8 
10.0 
5.0 
9.1 
7.1 
10.0 
RSV - A 
4.6 
0 . 0  
RSV - B 
10.0 
9.1 
RSV - C 
7.2 
10.0 
13.6 
20.0 
0 .0  
0 .0  
21.4 
10.0 
22.7 
70.0 
0 . 0  
18.2 
64.3 
70.0 
Table 25. Percentage of pock count on chorio-allantoic membranes (CAMs) from inoculation of RSV-
subgroups A, B and C between B complex alleles of line HN 
B Complex No. % Pock Counts 
Allele Embryos 0 1-25 26-50 51-75 76+ 
RSV - A 
12 16.7 8.3 8.3 0.0 66.7 
15 53.3 26.7 13.3 6.7 0.0 
BV 11 . 9.1 0.0 9.1 
RSV - B 
0.0 81.8 
Bl^BlS 13 0.0 7.7 7.7 7.7 76.9 
B^V2 12 25.0 8.3 33.3 16.7 16.7 
B^Bl 10 10.0 10.0 0.0 
RSV - C 
20.0 60.0 
11 9.1 9.1 0.0 9.1 72.7 
Bl2Bl2 13 61.5 15.4 7.7 7.7 7.7 
B^B^ 11 54.5 9.1 0.0 18.2 18.2 
Table 26. Percentage of pock count on chorio-allantoic membranes (CAMs) from inoculation of RSV-
subgroups A, B and C between B complex alleles of line M 
B Complex 
Allele 
No. 
Embryos 
% Pock Counts 
0 1-25 26-50 51-75 76+ 
RSV - A 
13 53.8 23.1 7.7 7.7 7.7 
3:5: 19 84.2 15.8 0.0 0.0 0.0 
16 43.8 25.0 6.2 
RSV - B 
12.5 12.5 
B^B^ 13 69.2 30.8 0.0 0.0 0.0 
B^B^ 17 94.1 5.9 0.0 0.0 0.0 
B^B^ 14 71.4 21.4 7.2 
RSV - C 
0.0 0.0 
13 38.5 15.4 7.7 7.7 30.7 
B^B^ 12 50.0 8.3 16.7 8.3 16.7 
B^Bl 10 10.0 0.0 10.0 10.0 70.0 
Table 27, Percentage of pock countoon chorio-allantoic membranes (CAMs) from inoculation of RSV-
subgroups A, B and C of lines WR and WS 
No. 
Line Embryos 
WR 16 93.8 
WS 14 7.2 
WR 28 64.3 
WS 23 43.5 
WR 13 76.9 
WS 11 36.4 
% Pock Counts 
1-25 26-50 5>T5 76+~ 
RSV - A 
6.2 0.0 0.0 0.0 
21.4 14.3 21.4 35.7 
RSV - B 
32.1 3.6 0.0 0.0 
21.7 26.1 8.7 0.0 
RSV - C 
15.4 7.7 0.0 0.0 
18.2 9.1 9.1 27.2 
Table 28. Percentage of pock count on chorio-allantoic membranes (CAMs) from inoculation of RSV-
subgroups A, B and C between B complex alleles of line 19 
B Complex 
Allele 
No. 
Embryos 
% Pock Counts 
0 1-25 26-50 51-75 76+ 
RSV - A 
B15.1J15.1 13 7.7 0.0 7.7 7.7 76.9 
B"B" 22 0.0 4.5 4.5 9.1 81.9 
25 8.0 8.0 4.0 
RSV - B 
24.0 56.0 
b15.1J15.1 12 75.0 16.7 8.3 0.0 0.0 
B"B" 11 9.1 9.1 0.0 27.3 54.5 
B^l 20 10.0 15.0 
V. 
10.0 
RSV - C 
5.0 60.0 
315.1^15.1 10 30.0 10.0 10.0 10.0 40.0 
B"B" 10 - 40.0 10.0 10.0 20.0 20.0 
15 6.7 0.0 0.0 6.7 86.6 
Table 29. Percentage of pock count on chorio-allantoic membranes (CAMs) from inoculation of RSV-
subgroups A, B and C between B complex alleles of lines 8 and 9 
Line 
B Complex 
Allele 
No. 
Embryos 
% Pock Counts 
1-25 26-50 51-75 76+ 
9 
8 
9 
8 
9 
.8 
Bl5.1gl5.1 
filS.lplS.l 
BI5.I3I5.I 
bIS.I^IS.I 
B^B^ 
bIS.I^IS.I 
Bis.ys.i 
B^B^ 
20 
25 
10 
19 
24 
10 
14 
13 
12 
45.0 
56.0 
20.0 
94.7 
91.7 
90.0 
71.4 
76.9 
66.7 
RSV - A 
15.0 
8.0 
0.0 
RSV - B 
5.3 
0.0 
10.0 
10.0 
8.0 
10.0 
0.0 
8.3 
0.0 
RSV - C 
21.5 
15.4 
16.7 
7.1 
7.7 
8.3 
10.0 
12.0 
10.0 
0.0 
0.0  
0 .0  
0 . 0  
0,0 
8.3 
20.0 
16.0 
60.0 
0.0 
0.0  
0 .0  
0.0 
0.0 
0.0  
